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PREFACE 
This master thesis has been written in the context of the 2020 global pandemic caused by SARS-CoV-2. 
Originally, the thesis was designed as practical work based in the study of neuroblastoma vascularization 
and differentiation through the use of biomaterial engineering. However, in mid-March (after three weeks 
of starting my work) exceptional situation and lockdown measures were taken by the Spanish Government, 
making impossible further laboratory work. This forced a change in the practical scope of the thesis towards 
a more theoretical approach.  
To diverge from a purely bibliographical and systematic review work I, at the proposition of my tutor, Dr. 
Aranzazu Villasante, accorded to implement the use of practical cases as the basis for a thesis in the shape 
of a research proposal. For 6 weeks after the lockdown measures started, I produced five practical cases 
based on the critical analysis of 5 scientific publications related to neuroblastoma and/or biomaterial 
engineering. The cases consisted of answering a set of questions proposed by Dr. Villasante. This set of 
questions included at its end a section demanding a new hypothesis based on the knowledge created by the 
discussed publication, as well as the necessary experiments to test that hypothesis. Once each case was 
finished, Dr. Villasante and I would discuss it via videoconference.  
With some modifications and refinements, these hypotheses became the backbone of the research proposal 
here presented. In consequence, the proposed experimental design is in part inspired by the techniques and 
methods utilized in these articles. Given the fact that the Master in Biomedicine and Biotechnology is 
oriented towards academic research, I have designed the project to fit the timescale of a doctoral project, 
being achievable in approximately three years. 
This document contains said research proposal, while the annex contains the five practical cases.  
Last, but not least, I would like to thank Dr. Villasante for her patience, guidance, and goodwill even through 
these strange times. I would also like to thank and acknowledge Prof. Gabriel Moncalián’s flexibility, 
support, and understanding in the previous, particular circumstances that I had to confront.  
Thank you, Arantza, and thank you, Gabi. Thank you very much. 
 
 
 
 
To my sister, Sara, without whom this master’s thesis work would have never taken place. Thank 
you for pressing that button for me. 
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ABSTRACT 
Neuroblastoma (NB) is the most common extracranial solid tumor in children and is frequently diagnosed 
at a metastatic stage. Despite therapy, tumor relapse occurs for around 50% of high-risk NB patients. At 
relapse, these patients have a very poor prognosis and overall survival rate decreases. The mechanisms 
behind NB relapse are not well understood, but recent studies suggest that chemoresistant dormant cells 
are in part responsible for tumor recurrence.  
Fibronectin (Fn) is an extracellular matrix protein (ECM) shown to promote breast cancer cell dormancy in 
a TGFβ1-dependent manner. Fn presents three regions of alternative splicing: extra domain A (EDA), extra 
domain B (EDB), and type III constant segment (IIICS). The presence of EDA-containing Fn (EDA+ Fn) 
in the ECM generates a positive feedback loop by activating the TGFβ1 signaling pathway, which in turn 
promotes the expression of EDA+ Fn.  
Besides its role in dormancy, the activation of the TGFβ1 signaling pathway promotes the differentiation 
of stromal fibroblasts towards cancer-associated fibroblasts (CAFs), which are known to promote tumor 
progression and chemoresistance. 
Altogether, we hypothesized that the ECM protein fibronectin, and specifically EDA+ Fn, could play a 
critical role in neuroblastoma dormancy, chemoresistance, and relapse by activating the ERK signaling 
pathway in NB cells and the TGFβ1 signaling pathway in fibroblasts of the tumor environment. 
To validate our hypothesis here we propose three specific aims; (i) to demonstrate that fibronectin induces 
cancer cell dormancy and relapse in neuroblastoma; (ii) to elucidate the role of the EDA domain in Fn-
induced dormancy and relapse; (iii) to demonstrate how EDA+ Fn plays a crucial role in CAF activation, 
initiating an ECM-remodeling process that promotes tumor growth and progression.  
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SPECIFIC AIMS 
Cancer cell dormancy is a clinically undetectable state of tumor cells underlying minimum residual disease, metastasis, and 
cancer relapse among others (Jahanban-Esfahlan et al., 2019). Neuroblastoma (NB), on the other hand, is the most common 
extracranial solid tumor in children and often has a poor prognosis (Modak and Cheung, 2010). More than half of the patients 
have a metastatic disease at diagnosis, and approximately 50% of children with high-risk NB that complete consolidation therapy 
will suffer an early or late relapse (Reynolds, 2004). 
Despite its key importance in relapse and metastasis, cancer cell dormancy is poorly understood. However, a very recent 
publication by Barney et al. (2020) used an in vitro model of cell dormancy, showing how extracellular matrix (ECM) 
composition is a key contributor to this process in breast cancer cells, demonstrating how tumor-cell secreted fibronectin 
(TCFn) matrixes can improve very significantly cancer cell survival during long dormancy periods.  
While TCFn matrixes strongly enhance cell dormancy, cells grown on plasma fibronectin (pFn)-coated surfaces exhibit 
diminished survival rates. To date, the mechanism causing this drastic reduction between cells grown in TCFn and pFn 
remains unknown. We propose a driving mechanism: the fibronectin gene displays alternative splicing, and up to 20 
variants exist in the human organism. Through extensive bibliographical research, we have identified a specific Fn domain, 
Extra Domain A (EDA), which is present in TCFn and not in pFn, and possesses unique characteristics. 
EDA-containing fibronectin (EDA+ Fn) has a 5-fold higher ability to attract and bind latent TGFβ binding protein 
(LTBP1; Klinberg et al., 2018) than pFn, and is a necessary element of TGFβ1-dependent myofibroblast differentiation (Serini 
et al., 1998), potentially facilitating the activation of cancer-associated fibroblasts (CAFs).  
Biomaterials and tissue engineering offer interesting tools to study cell-ECM interactions in both 2D and 3D cultures 
where ECM composition and mechanical constraints can be defined at will; as well tools to research interactions between 
different cell types, using techniques such as micropatterning to study cell interactions in a spatially controlled manner while 
maintaining a defined ECM.    
The information gathered led us to hypothesize that EDA+ Fn expression by cancer cells in neuroblastoma enables cancer 
cell dormancy when tumor cells face adverse conditions, while at the same time triggering the activation of local fibroblasts 
leading to the appearance of CAFs. Our long-term goal is to validate this hypothesis using techniques based on biomaterial 
and tissue engineering.  
We are proposing to accomplish this hypothesis with the following specific aims: 
1. To study cancer cell dormancy in neuroblastoma, we will reproduce some of the experimental approaches done 
in breast cancer cell lines by Barney et al. using serum deprivation as a mean to induce dormancy, testing a 
variety of NB cell lines with varying capacity to produce metastases and relapse. 
2. To verify the impact of fibronectin’s EDA domain in dormancy, we will study the expression and localization 
of Fn splice variants and different integrins along the set of NB cell lines, comparing their ability to enter 
dormancy with their Fn and integrin expression and distribution patterns. 
3. To study the interactions between NB cells and fibroblasts with special attention to EDA+ Fn and CAF 
differentiation, we will use different co-culture methods including micropatterning and 3D porous scaffolds. 
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INTRODUCTION 
Neuroblastoma 
 Epidemiology 
Neuroblastoma (NB), is a highly vascularized cancer of the sympathetic nervous system, and the most 
common extracranial solid tumor of infancy. It is a clinically heterogeneous malignancy that accounts for 
15% of cancer deaths in children, with an incidence of 10.2 cases per million children under 15 years of age 
(Park et al., 2010). Neuroblastoma prognosis correlates with the patient’s age at the time of diagnosis and 
the degree of differentiation, with outcomes varying from high rates of survival to recurrence and mortality. 
Grave prognosis, however, is common. The difficulty at diagnosing NB causes that more than half of the 
cases are detected at the metastatic stage (Reynolds, 2004). Besides, it is estimated that 50-60% of children 
in the high-risk group who complete consolidation therapy experience an early or late relapse (Maris, 2010). 
The clinical relevance of metastases and relapse in neuroblastoma, being both processes governed by the 
ability of the tumor to survive during extended periods of adverse conditions and capacity to alter its 
microenvironment to a more favorable one, makes especially relevant the study of cancer cell dormancy and 
its relationship with the extracellular matrix (ECM) in this kind of tumor. 
 Biology 
The degree of differentiation of a tumor measures the phenotypical variation of the tumor’s cells respect 
their original tissue or organ; being very differentiated those cells closely resembling their healthy tissue 
counterparts, and poorly differentiated those cells whose phenotype has drastically shifted from these. The 
process through which tumor cells undergo a phenotypic change, losing their original characteristics, is 
called de-differentiation. De-differentiated cells suppose a major risk for cancer patients, as they possess 
enhanced plasticity and multipotency, granting them higher possibilities of invading new environments 
different from their original niche, producing metastases. When studying neuroblastoma differentiation is a 
subject of great relevance, both clinically and biologically.  
From a clinical point of view, NB de-differentiation correlates with a bad prognosis. Interestingly, it is 
sometimes reverted spontaneously by a re-differentiation event, causing a sudden regression of the disease 
(Nakagawara, 1998; Nickerson et al. 2000). This discovery has led to therapies based on the induction of re-
differentiation using isotretinoin (13-cisretinoic acid) which have been incorporated into multimodal 
treatments for patients with high-risk neuroblastoma (Brodeur and Bagatell, 2014; Brodeur, 2018).  
From a biological point of view, and especially for those studying neuroblastoma in vitro, it is of key 
importance to note the findings done by Lam et al. (2010; practical case 1).  In their article, they described 
how the stiffness of the extracellular matrix alone can induce neuroblastoma cell redifferentiation. ECM 
stiffness refers to the elasticity of the substrate in which cells are embedded, or in the case of two-
dimensional (2D) in vitro cultures, to the stiffness of the culture substrate utilized. It is measured through 
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Young’s elastic modulus (E) using pascals (Pa) as the unit. According to Lam et al., neuroblastoma cell lines 
grown on low stiffnesses of 0.1 to 1 kPa will stay in their natural dedifferentiated, multipotent state, while 
they shift their phenotype to a neuron-like one when grown in substrates with stiffnesses over 50 kPa, thus 
suffering a redifferentiation process. Classical culture surfaces such as polystyrene tissue culture plates and 
glass culture surfaces lay in the MPa range (Pelham and Wang, 1997). This represents a challenge when 
studying most neuroblastoma cell lines in vitro. The stiffness-induced re-differentiation process makes it 
necessary for researchers to implement biomaterial engineering culture methods in their experimental 
designs. By culturing NB cells in surfaces with a tailored stiffness, this artifactual re-differentiation process 
can be avoided. 
Another important characteristic of neuroblastoma’s biology is cancer cell dormancy. It is one of the 
possible mechanisms behind chemoresistance and common relapses (Veschi et al., 2019). Cancer cell 
dormancy is the process through which a tumor cell enters a state of quiescence, suffering cell cycle arrest 
and becoming insensible to the cytostatic drugs used in chemotherapy (Ranganathan et al., 2006). A recent 
article by Barney et al. (2020; practical case 4) describes one possible mechanism behind cancer cell 
dormancy: tumor cell-secreted fibronectin (TCFn) strongly promotes cell survival during long periods of 
serum deprivation in breast cancer cells. Importantly, they found that fibronectin purified from human 
plasma (pFn) fails to produce this same effect. The authors also described how when cells are incubated 
with transforming growth factor-β1 (TGFβ1) during the serum starvation assays, TCFn secretion was 
significantly increased. Opposingly, TGFβ receptor inhibition it shut off almost completely, implying that 
fibronectin-induced dormancy dependent on TGFβ1 signaling 
Cancer-associated fibroblasts  
Today, the consensus is that tumors are composed of both cancer cells and stromal cells (i.e. immune cells, 
fibroblasts, etc) and that their interactions have crucial importance in cancer biology (Hashimoto et al., 
2016). Like many other cell types found in tumors, cancer-associated fibroblasts (CAFs) present an altered 
phenotype induced by cancer cells. This new phenotype, similar to that of myofibroblasts, grants them a 
key role in ECM regulation in the tumor niche. Given their similarity, both CAFs and myofibroblasts can 
be identified using α-Smooth muscle actin (α-SMA) as a molecular marker, since its expression is highly 
upregulated as a result of their activation. 
Although normal non-activated fibroblasts are present too in the tumor stroma, the majority of present 
fibroblasts are CAFs presenting this secreting phenotype. Importantly, these CAFs do not return to a normal 
state as myofibroblasts do under physiological conditions, maintaining a perpetual fibrogenic activity 
(Tomasek et al., 2002). The ECM remodeling caused by CAFs promotes cancer proliferation, invasiveness, 
angiogenesis, and progression, resulting in an increased overall tumor ability to proliferate and produce 
metastases (Vong and Kalluri, 2011). 
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Tissue and biomaterial engineering 
 Surface stiffness and cellular biology 
Pelham and Wang (1997) first described how substrate stiffness could affect cellular motility and 
morphology in fibroblasts. Since then, substrate stiffness has been shown to affect adhesion, migration, cell 
differentiation and proliferation, angiogenesis, tumor metastasis, embryonic development, and other 
processes (Wells, 2008; Xia et al., 2017). In this context, it is worth recalling how substrate stiffness drives 
neuroblastoma cell differentiation with the consequent loss of “stemness” as explained above (Lam et al., 
2010).  
The elastic modulus of the ECM varies greatly across the different human tissues and organs, being the 
brain’s E the lowest in the human body at several hundred pascals (Pa). Muscle’s E is around 12 kPa, while 
tendons and cartilages lay in the megapascal range (Levental et al., 2007). Bone, the hardest tissue, has an 
average E of 10 to 20 GPa (Rho et al., 1993). It is key to point out how ECM-remodeling processes such as 
fibrosis can drastically change the stiffness of a tissue. While a normal liver has a stiffness slightly higher 
than that of the brain, around 500 Pa, the changes to the ECM caused by fibroblast pathological activation 
can increase its E to 20 kPa (Georges et al., 2007). ECM-remodeling processes are also of importance in 
tumors and can be associated with malignancy (Wullkopf et al., 2018).  
The relevance of substrate stiffness in cell biology has led to the development of several methods for cell 
culture under controlled mechanical conditions. These are based on the fabrication two-dimensional (2D) 
and three-dimensional (3D) substrates where the ratio of a polymer vs. a crosslinker agent is used to tune 
the stiffness. Higher ratios of the crosslinker agent allow for the formation of more covalent bonds in the 
material, resulting in a higher elastic module (Yan et al., 2019). The materials utilized to manufacture the 
substrates vary depending on their applications and their dimensionality, being polydimethylsiloxane 
(PDMS, a kind of silicone) a common compound used for 2D applications. Conversely, ECM proteins such 
as collagen-I or inert proteins such as silk fibroin are the among most common materials used for 3D 
applications.   
 Two-dimensional substrates and micropatterning 
PDMS is routinely used in biomaterial engineering to produce 2D cell culture substrates of determinate 
stiffnesses with ease. It is a commercially available, elastic, non-toxic, transparent, biocompatible, and 
hydrophobic polymer, making it an interesting material to implement in cell culture (Raczkowska et al., 
2016). Given its hydrophobic nature, surface functionalization is necessary for cell adhesion. Approaches 
such as UV-ozone treatment can be used to ionize the silicone surface improving its protein adherence and 
wettability. However, this modification produces a surface capable only of forming ionic bonds with a 
coating, which are not desirably durable. To avoid this, carbodiimide crosslinking chemistry can be used to 
form covalent bonds between PDMS and a coating molecule, strongly stabilizing the interaction (Zhou et 
al., 2011).  
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Other compounds can also be used to produce substrates with controlled stiffness. Lam et al. (2010; 
practical case 1) used polyacrylamide to produce gels of stiffnesses ranging from 0.01 kPa to 1000 kPa. 
However, a complex manufacturing process was necessary to modify the polyacrylamide surface to reduce 
its cytotoxicity (Ulrich et al., 2009). 
The coating process can be further tweaked with the use of antifouling layers or microcontact printing to 
produce micropatterned surfaces where one or more proteins of interest are inlaid in a spatially controlled 
manner (Martinez-Rivas et al., 2017). These techniques allow for the study on how ligand disposition, cell 
cluster shape, and inter-cellular tension affect cell biology (McBeath et al., 2004). They can also be used for 
the implementation of co-culture methods where different cell types are confined in discrete, spatially 
controlled patterns to study their interaction (Dickinson et al., 2012; practical case 2). When using 
microcontact patterning for the study of cellular interactions among two cell types, it may occur that a valid 
couple of cell type-specific ligands cannot be found. This may make it impossible to have two different cell 
types exclusively bind a single type of ligand molecule in the pattern. In these cases, it is possible to combine 
different patterning strategies to circumvent the lack of ligand-cell type specificity. 
When using materials like PDMS for micropatterning, the coated areas of the pattern can be surrounded by 
non-coated, non-adherent surfaces, strictly confining cell growth to the coated areas. By altering the shape 
and size of these coated areas, the number of cells per cell cluster can be adjusted. Altering these parameters 
can alter cell proliferation and behavior (Mammoto et al., 2004). This technique has also been used to 
determine mesenchymal stem cell (MSC) differentiation fate, as bigger cell groups can establish stronger 
cell-ECM and cell-cell adhesions. These adhesions allow cells to subject each other to higher tensions than 
cells confined in smaller clusters, leading to a mechanosensing-dependent differentiation process where the 
MSCs differentiate into the three mesenchymal lineages depending on cell cluster size (McBeath et al., 2004).  
Another article by Shimizu et al. (2014; practical case 3) represents an impressive advance in patterning 
technology and its potential, shifting our technical ability to produce patterns from the micro- to the 
nanoscale (Shimizu et al., 2014). The researchers were capable of deploying a quasi-hexagonal pattern of 10 
nm gold particles coated with the cyclic peptide cRGD (capable of binding a wide range of integrins) where 
the size of the gold nanoparticles allows for a single integrin dimer to bind a single nanoparticle. 
Furthermore, they used photocleavable PEG12K as an antifouling agent in the nanoparticles, allowing them 
to photoactivate the surface. This way only the UV-irradiated areas are cell-adhesive, enabling for the 
performance of clean, high-resolution cell migration assays where integrin ligand availability and spacing can 
be tightly controlled. 
 Three-dimensional cultures 
Most cell types in the human organism, if not all, grow and thrive in heterotypic three-dimensional 
environments where cells are completely embedded in the ECM. This is not restricted to physiological 
tissues and organs: it is also common to pathological structures such as tumors. However, since the advent 
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of cell culture, methods for the culture of cells have mainly focused on homotypic 2D monolayers grown 
in either glass or polystyrene surfaces. These conditions are unfortunately distant from the physiological 
environments that cells usually inhabit. Today, it is well known that cells grown on traditional 2D culture 
surfaces behave differently as they would do in a 3D culture environment or in vivo (Benton et al., 2009; 
Fraley et al., 2010). 
During the last two decades, different strategies for the development of three-dimensional culture systems 
have been used. The use of spheroids and porous scaffolds are among the most relevant techniques 
(Haycock, 2010). Spheroids exploit the tendency of most cell types to aggregate naturally, using techniques 
such as hanging drop or concave wells to concentrate suspended cells around the apex of the droplet or 
well thanks to gravity (Froehlich et al., 2016). Porous scaffolds, conversely, are based on the manufacturing 
of protein-based 3D matrixes. These allow for the study of cell-ECM interactions in an environment where 
the matrix mechanical and molecular properties can be controlled by the researcher, in opposition to 
spheroids where cells freely assemble their 3D matrix (Carletti et al., 2010). Porous scaffolds can be 
manufactured utilizing a vast amount of techniques: solid free-form fabrication technologies (such as 3D 
printing), electrospinning of nanofibers into random patterns, or freeze-drying fabrication.  
Fibronectin biology and alternative splicing 
Fibronectin is a 440-kD dimeric glycoprotein widely distributed in plasma and in the ECM (Kurkinen et al., 
1980). Since the ‘80s, it’s been known that the fibronectin gene presents alternative splicing. Ruoslahti (1988) 
published an extensive review on fibronectin biology and biochemistry, where a report of the up to 20 
described fibronectin splice variants is included. Fibronectin has three domains that present alternative 
splicing: extra domains A (EDA), extra domain B (EDB), and the type-III constant domain (IIICS). 
Domains EDA and EDB are mutually exclusive, and are never present in plasma Fn, while the IIICS domain 
can be present in it.  
Both EDA+ and EDB+ fibronectin are oncofetal isoforms, given the fact that their expression patterns are 
restricted to development, but re-gained in tumors (Kumra and Reinhardt, 2016). Therefore, both isoforms 
can be present in TCFn. Besides its localization in tumors, EDA+ Fn can be found in wound healing and 
in fibrotic lesions, where it is secreted by fibroblasts causing their activation and differentiation towards the 
myofibroblast phenotype (White and Muro, 2011). Conversely, EDB+ Fn can also be found in proliferative 
diabetic retinopathy (PDR). It is of interest to note that EDB+ Fn localization in tumors and PDR is mainly 
restricted to blood vessels, and plays a direct role in tumor vasculogenesis (Khan et al., 2005). 
EDA Fibronectin 
The presence of the EDA domain grants ECM fibronectin improved functionality. EDA+ Fn potentiates 
cell cycle progression and ERK signaling more strongly than EDA- Fn (Manabe et al., 1999). This correlates 
with the results obtained by Barney et al. (2020), where inhibition of ERK signaling of tumor cells growing 
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in TCFn reduces cell survival rates to levels found in cells growing in neutral collagen I coating. Additionally, 
the presence of this domain is necessary for TGFβ1-dependent myofibroblast differentiation (Serini et al., 
1998). This could link the expression of EDA+ Fn to CAF activation and ECM remodeling.  
Serini et al. (1998) described three key factors underlying TGFβ1-dependent myofibroblast differentiation. 
First, EDA+ Fn expression is increased when fibroblasts are incubated with TGFβ1, and the expression of 
EDA+ Fn precedes that of the myofibroblast differentiation marker α-SMA is expressed. This hints that 
this Fn isoform may mediate a step of the differentiation process. Second, the incubation of fibroblasts with 
IST-9 (an antibody specifically binding the EDA domain of Fn) shuts down TGFβ1 activation and therefore 
fibroblast differentiation towards the myofibroblast phenotype. Antibodies targeting other Fn domains do 
not have the same effect, highlighting the necessity of EDA’s functionality for this activation process. Third, 
given that active TGFβ1 increases EDA+ Fn expression, and that EDA+ Fn increases latent TGFβ1 
activation, both molecules act synergistically forming a positive feedback loop that ultimately leads to 
fibroblast differentiation. 
Later in time, EDA+ fibronectin was shown to be essential for the association of latent TGFβ binding 
protein 1 (LTPB1) to the ECM (Zilberberg et al., 2012). It was also found that EDA+ Fn binds LTBP1 
twice as efficiently as its pFn counterpart, and EDA blockage with the IST-9 antibody reduced the ratio of 
active TGFβ1 10-fold as a result of LTBP1 binding competition (Klinberg et al., 2018). These findings 
synergize with those of Serini et al (1998), partially unveiling the mechanisms behind TGFβ1-dependent 
fibroblast differentiation. 
 Integrin biology   
Fibronectin, as well as many other ECM proteins, interacts with cells by binding integrins. Integrins are 
heterodimeric transmembrane proteins with intra- and extracellular domains that link the cytoskeleton to 
the ECM. Their function is not merely structural: they also activate signaling pathways, acting as a 
biomechanical sensor. They are composed of two subunits: one of the α type and one of the β type. 18 
different α and 8 β subunits exist, which can combine to form at least 24 identified heterodimers in vivo 
(Kechagia et al., 2019).  
Fibronectin contains a vast amount of integrin-specific binding motifs that enable cell adhesion. More 
specifically, the EDA domain contains a unique motif (residue sequence EDGIHEL) which binds integrins 
α4β1, α4β7, and α9β1. Both α4β1 and α4β7 can bind other domains of fibronectin, but these binding sites 
are composed of a different motif, which may have consequences over binding and function (Yalak et al., 
2019). Interestingly, Horwacik and Rokita (2017; practical case 5) published the results of a partial integrin 
screening over the neuroblastoma cell lines IMR-32, CHP-134, LA-N-5, and Kelly. With it, they were able 
to show how only the cell lines expressing high levels α4 and β1 can attach to and grow in fibronectin 
matrixes, being both processes reversible by using the α4β1 inhibitor BIO1211. These findings highlight the 
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importance of integrin expression patterns when studying the effect of cell-ECM interactions and exhibit 
the utility of using integrin inhibition for such studies. 
Additionally, and as a note of importance, EDA+ Fn has been shown to induce the aforementioned 
fibroblast differentiation process by binding to the α4β7 integrin in lung stromal fibroblasts (Kohan et al, 
2010), one of the three integrins shown to bind EDA. This gives further importance to the study of the role 
of integrin expression in fibronectin-dependent cell dormancy. 
HYPOTHESIS 
Summarizing the key concepts of the introduction, our research hypothesis is based on the following 
published research data and assumptions: 
1. Cancer cells under serum starvation express TCFn which in turn promotes cancer cell dormancy and 
survival. However, pFn fails to produce the same effect.  
2. Expression of TCFn in serum-starved cancer cells can be increased with exogenous TGFβ1 and 
inhibited with a TGFβR inhibitor (Barney et al. 2020).  
3. EDA+ Fn expression is increased in the presence of TGFβ1 (Serini et al., 1998). These findings point 
towards the possibility that the TCFn produced by dormant breast cancer cells is in fact of the EDA+ 
isoform.  
4. EDA+ Fn is necessary for fibroblast activation and phenotype switch, a process that leads to increased 
TGFβ1 expression with the resulting positive feedback loop (Serini et al., 1998).  
5. The ECM-remodeling process triggers the transition from healthy fibroblasts to the CAF phenotype and 
also plays a role in tumor progression (De Wever et al., 2008).  
Taken all together we can establish the following hypothesis: 
(i) Neuroblastoma cells express EDA+ Fn when facing adverse conditions such as serum starvation, what 
activates (ii) a short-term autocrine signaling pathway capable of enabling cell dormancy mediated by 
integrin and ERK signaling, and (iii) long-term paracrine signaling that favors the differentiation of stromal 
fibroblasts towards a CAF phenotype mediated by integrins and TGFβ1 signaling.  
The combination of autocrine and paracrine signaling could give NB-EDA+ cells the tools to survive to 
processes like chemotherapy by entering dormancy and to recover thereafter by altering their ECM and 
microenvironment. Given the clinical relevance of relapse in neuroblastoma, we believe that the discovery 
of the involvement of EDA+ Fn in this phenomenon would open the door for better therapies.  
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Fig 1. Graphical model illustrating the three sections of our proposed hypothesis. For illustration 
comprehensibility, the interactions between integrins and the cytoskeleton have not been represented. This 
note is for clarifying that, despite how integrins have been depicted, they are not to be confused with common 
transmembrane receptors such as the TGFβ receptor.  
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OBJECTIVES 
In order to validate the proposed hypothesis, the following objectives will be pursued: 
1. To successfully translate the use of serum starvation as an inducer of fibronectin-dependent cancer cell 
dormancy as described by Barney et al. (2020) to study cancer cell dormancy in neuroblastoma. 
2. To verify that the EDA domain is a necessary element for fibronectin-dependent dormancy, elucidating the 
role of integrin signaling and the TGFβ1 - EDA+ Fn positive feedback loop in this process. 
3. To study the effects of EDA+ fibronectin secretion over normal fibroblast populations, carefully examining 
their possible differentiation towards a pro-fibrotic, cancer-associated fibroblast phenotype with the 
subsequent remodeling of the ECM, promoting a pro-tumorigenic microenvironment.  
MATERIALS AND METHODS 
Preparation of functionalized 2D substrates of physiological stiffnesses 
To produce 2D substrates with controlled mechanical and biochemical properties, we will utilize PDMS 
and carbodiimide chemistry. We will fabricate these substrates in multi-well plates to augment the capacity 
of our experimentation throughput to be able to test a wide range of NB cell lines. 
To produce substrates of a desired stiffness, first we will need to calibrate the stiffness that a specific PDMS-
to-curing agent ratio yields (PDMS mass to Curing agent mass; hereby P:C ratio). For this, we will produce 
PDMS cylinders of 10 mm diameter and 7 mm height using molds and the P:C ratios for each type of PDMS 
established in Table 1. The conventional type of PDMS used for the fabrication of substrates, Sylgard 184, 
cannot reach stiffnesses of 1 kPa and below. To reach these lower stiffnesses we will use Sylgard 527 PDMS, 
which can reach elastic moduli of down to 0.1 kPa (Moraes et al., 2015). The different PDMS and curing 
agent mixtures will be prepared, cast in the molds, and cured in a dry oven at 60 ºC for 4 hours. 
Table 1. Ratios of PDMS to curing agent used to produce the samples for the study of P:C ratio impact 
over substrate stiffness, based on published methods (Moraes et al., 2015). Small variations in the ratio 
cause drastic variations in Sylgard 527 after curing, for what the differences between P:C ratios are smaller.  
PDMS type P:C ratio (m:m) 
Slygard 184 
70:1 
50:1 
25:1 
10:1 (~1000 kPa) 
Sylgard 527 
5:4 (~1 kPa) 
1:1 (~0.1 kPa) 
4:5 
2:3 
1:2 
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The cured PDMS cylinders will then be subject to compressive tests using a texture analyzer in the style of 
XT-PLUS (TA instruments). This device produces a deformation in the material and measures the resulting 
force-displacement curve, which is used to calculate the elastic modulus. The E of cylinders of each P:C 
ratio will be measured in triplicate, and the average measurements used to perform a regression curve. This 
curve will be used to calculate the P:C ratios required to produce substrates of each experiment’s desired 
stiffnesses. 
The 2D soft substrates will be fabricated in multi-well well plates by pouring the desired mixture of PDMS 
and curing agent in each well and curing it at 60 ºC for 4 hours. Once cured, the substrates will be subject 
to UV/ozone activation for 5 minutes and incubated in a crosslinking solution containing 0.05 M MES 
buffer, 0.5 M NaCl, 0.1 M 1-ethyl-3-(-3-dimethylaminopropyl) carbodiimide hydrochloride (EDC), and 0.1 
M N-Hydroxysuccinimide (NHS) for 15 minutes in the dark. The wells will then be washed repeatedly with 
PBS buffer, letting the PBS sit for 5 minutes during each wash and avoiding letting the wells dry between 
washes.  
At this point, the PDMS surfaces can be coated by incubating a concentrated solution of the desired protein 
or polypeptide at 4 ºC in the dark for 16 hours. After incubation with the desired protein, several PBS 
washes must be performed given that EDC and NHS are cytotoxic compounds. At this point, the plates are 
ready to use in experiments. 
For the scope of this project, two different kinds of coatings will be used; one based in poly-D-lysine (PDL), 
used to study the capacity of cells to produce a dormancy-inducing ECM themselves; and one based in 
EDA+ fibronectin to study whether this isoform is responsible for the dormancy-inducing effect. Cellular 
fibronectin (supposed to include the EDA domain) can be outsourced from two companies producing and 
selling cellular Fn (ScienCell, cat. no. 8488; Sigma-Aldrich, cat. no. F2518). We will request information 
about the splicing variants of their products to verify whether they do include the EDA domain, and source 
our EDA+ Fn from any of them in case their product is EDA positive. 
Preparation of 3D porous scaffolds 
Some of the experiments of this project will require the use of 3D culture methods. For this, we will use 
freeze-drying fabrication, which allows for batch manufacturing of scaffolds. This technique starts with a 
highly concentrated solution of a given protein which is placed in a mold and frozen at -40 ºC (fig. 2). The 
ice crystal formation during the freezing process is exploited to produce gaps in the sample. The frozen 
material is sublimated in a lyophilizer, leaving hollow pores where the ice crystals were, forming a dry protein 
scaffold. To resist dissolution when re-wetted, the scaffold must be subject to carbodiimide crosslinking. 
The covalent bonds formed in the crosslinking step make the structure stable in water.  
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Figure 2. Schematic representation of porous scaffold fabrication using freeze-drying fabrication. 
To produce our 3D scaffolds, we will use the freeze-drying technique as described by Villasante et al. (2016). 
To fabricate these porous scaffolds, 200 µL of a highly concentrated solution of silk fibroin (7 – 10 mg/mL; 
Sigma-Aldrich) will be pipetted in cylindrical molds of 8 mm diameter and 5 mm height and frozen at -40 
ºC for 4 hours. After freezing, the samples will be lyophilized at -40 ºC for 16 hours. Once lyophilized, the 
materials will be submerged in a crosslinking solution containing 95% v/v ethanol, 33 mM EDC, and 6 mM 
NHS for 4 hours at room temperature. The scaffolds will then be washed 5 times in distilled water, 5 minutes 
each time, re-frozen at -40 ºC for 4 hours, and re-lyophilized at -40 ºC for 16 hours. The proposed protocol 
produces scaffolds with an elastic modulus of approximately 1 kPa. At this point, dry scaffolds can be stored 
for days. Before their utilization, they must be sterilized by submerging them in 95% ethanol for 1 hour, 
washed 5 times in PBS buffer, and coated by submerging the scaffolds in a sterile PDL solution (0.1 mg/mL) 
for 1 hour at 37 ºC. 
Cell lines 
A set of 16 NB cell lines displaying different degrees of tumoral progression stemming from less aggressive 
malignancies to more aggressive will be studied in different experiments (Table 2). These cell lines have 
been chosen to cover all tumor stages, 1 to 4, including the stage 4S, a special classification for 
neuroblastoma. Stage 4S neuroblastomas have a higher spontaneous regression rate and a better prognosis 
than stage 4 patients (Taggart et al., 2011). The amplification state of MycN, which strongly correlates with 
prognosis and tumor aggressivity has also been assessed. Certain NB lines have been selected given specific 
characteristics that make them interesting for the scope of the study. These characteristics can be consulted 
in the Remarks section of Table 2. 
 
 
 
Table 2. Neuroblastoma cell lines selected for cell dormancy screening using the serum starvation method. BM = bone marrow, LN = lymph node, Unk. = unknown. 
Cell line Stage  
(Thiele, 1998) 
Metastasis 
(Thiele, 1998) 
MycN amplification 
(Harenza et al. 2017; 
Thiele, 1998) 
Integrin expression 
(Horwacik and Rokita, 
2017) 
Remarks 
CLB-Pe 1 No Yes - - 
STA-NB-3 2 No Yes - - 
NLF 3 No Yes, low - - 
WSN 3 No Yes - - 
NBL-S 3 No No - - 
CHP-134 4 LN Yes, medium α1, α4, αv, β1, β3 - 
LA-N-5 4 BM Yes, high α1, α2, αv, β1, β5  
SK-N-DZ 4 BM Yes, medium - Differentiates in stiffnesses over 50 kPa (Lam et 
al., 2010) 
SH-N-SH 4 BM No - Can induce VEGF-dependent angiogenesis (Li 
et al., 2013) 
LA-N-6 4 BM, bone No - - 
NGP 4 BM, lung Yes, high - - 
CLB-Ga 4 BM, LN, bone, 
mediastinum 
Yes - - 
NB69(2) 4 Lung, liver, sternum No - - 
NBL-W 4S Liver Yes - Stage 4S neuroblastoma exhibits a higher 
spontaneous regression rate (Taggart et al., 2011) 
IMR 32 Unk. Unk. Yes, low α1, α4, β1 - 
Kelly Unk Unk. Yes, high - - 
 
 
 
Serum starvation assays  
To study dormancy in neuroblastoma cells, we will use the in vitro cell dormancy protocol described by 
Barney et al. (2020), based on the use of serum starvation to induce dormancy. This method will be used 
routinely to study dormancy in a wide range of varying conditions. Serum starvation assays will be performed 
by seeding cell cultures onto a 2D substrate/3D scaffold depending on the experiment. Cells will be seeded 
at a concentration of 30,000 cells/cm2 in the multi-well plates. Once seeded in the substrate or scaffold, 
cells will be cultured in each cell line’s specific culture medium with no serum. The serum starvation assays 
will be performed, unless stated otherwise, using the following temporal schemes: 7-day serum-free culture, 
28-day serum-free culture, and 28-day serum-free culture followed by 7 days of culture with serum (fig. 3), 
being the last used to study cell recovery after dormancy. The culture medium will be changed every 2 to 3 
days.  
Figure 3. Schematic representation of culture conditions and periods used to determine NB cell line ability to 
enter and exit cell dormancy. 
Cell dormancy analyses 
Cell proliferation 
To assess cell proliferation in the serum starvation assays, we will use the Quant-iT™ PicoGreen™ dsDNA 
Assay Kit (Thermo-Fisher). This assay measures the amount of double-stranded DNA (dsDNA) found in 
a present sample, which correlates with cell density. It can be used to quantify cell populations both 2D and 
3D cultures.  
First, samples will be homogenized by incubating them in a digestion solution containing papain (125 
µg/mL), L-cysteine (2 mM), and EDTA (0.333 M) in PBS buffer. Incubation will take place in the multi-
well plates used for the starvation protocol, with mild shaking at 65 ºC for 16 hours. Once homogenized, 
100 µL of each sample will be transferred to a 96-well plate and combined with 100 µL of the PicoGreen™ 
reagent, previously diluted 20X with TE buffer (included in the kit). The samples will then be incubated at 
room temperature for 5 minutes and their fluorescence will be analyzed in a plate reader.  
To approximate the number of cells that corresponds to a given fluorescence intensity, each serum 
starvation assay will be complemented with homogenization and fluorescence analysis of a standard curve. 
The standard culture will be prepared by performing serial dilutions of a cell culture of known cell density. 
The dilutions will be digested and read in parallel together with the experimental samples.  
 
19 
 
Cell cycle 
To gain insight into the cell cycle status of different NB cell populations, we will use flow cytometry (FC) 
to assess the cellular DNA content and p21 and Ki67 expression. To study cell cycle arrest, we will use 
propidium iodide (PI), p21 as a marker for cell cycle arrest at the G0/G1 stage, and Ki67 as a marker for 
actively proliferating cells. 
For this, we will adapt the protocol published by Kim and Sederstorm (2015). First, we will harvest and fix 
cells by incubating them in a 70% ethanol solution at -20 ºC for 2 hours. Then we will rinse cells repeatedly 
with FC buffer (1X PBS supplemented with 2% fetal bovine serum and 1 mM EDTA) and incubate them 
with a FITC-conjugated anti-Ki67 antibody (Santa Cruz Biotechnology) or an Alexa-647-conjugated anti-
p21 antibody (Abcam) for 30 minutes. One set of samples will be used for each antibody. After this, samples 
will be rinsed with FC buffer and incubated with 50 μg/ml PI (Sigma-Aldrich) for 20 minutes. At this point, 
flow cytometry can be performed using the adequate lasers and filter settings to collect data.  
Immunostainings 
Certain experiments will evaluate the expression of a protein using immunofluorescence. In table 3, we 
compile the different proposed primary antibodies and the secondary antibodies needed for fluorescence 
microscopy imaging. For the staining protocol, cell cultures will be devoid of culture medium and washed 
with warm PBS.  
Table 3. Commercial antibodies destined to the study of fibronectin, EDA+ fibronectin, and αSMA 
expression using immunostainings and fluorescence microscopy.  
Protein Primary antibody, species of origin Secondary antibody  
Fn EP5, mouse mAb  
(Santa Cruz Biotechnology) 
Goat Anti-Mouse IgG-Alexa Fluor® 790 
(Abcam) 
EDA 
domain of 
Fn 
IST-9, mouse mAb 
(Abcam) 
αSMA 1A4, mouse mAb 
(Thermo Fisher) 
The cultures will then be fixed and permeabilized with a PBS solution containing 4% paraformaldehyde and 
0.2 Triton X-100 for 10 minutes. The samples will then be incubated with a blocking buffer containing 2% 
bovine serum albumin (BSA) in PBS for 30 minutes. Once blocked, the samples will be incubated with the 
primary antibody at the concentration recommended by the supplier for 2 hours at room temperature. Once 
this period ends, the samples will be washed three times with PBS and incubated with the secondary 
antibody for 1 hour. Finally, the samples will be washed again for three times, being ready to observe using 
fluorescence microscopy at this point. 
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Manufacturing dormancy-inducing decellularized matrixes  
To study the effects caused by ECMs produced by neuroblastoma cells exposed to serum starvation, some 
of our experiments will use decellularized matrixes. The ECM of cells grown in a coated culture substrate 
can be decellularized using the protocol developed by Castelló-Cros and Cukierman (2009). Following it, 
we will culture a cell line exhibiting high capacity to enter dormancy on soft 2D PDMS substrates coated 
with poly-D-lysine in multi-well plates. This hypothetical cell line will be referred to as the HDC (High 
Dormancy Capacity) cell line from now on. The HDC cells will be seeded at a density of 30,000 cells/cm2 
in serum-free medium for 28 days. This is the period required for cells to produce a dormancy-inducing 
ECM (Barney et al. 2020). After this, the culture will be exposed to phosphate-buffered saline (PBS) 
containing 0.5% Triton X-100 and 20 mM NH4OH at 37 ºC for 10 minutes. This incubation should destroy 
cytoplasmic membranes, therefore eliminating the cells from the matrix. The cell debris will be washed 
repeatedly with PBS, after which the cells will be kept for 1 month at 4 ºC. The decellularized matrixes are 
ready to use after this period (Castelló-Cros and Cukierman, 2009).  
EDA+ inhibition and competition assays 
To test the relevance of EDA+ Fn signaling in dormancy, we will study the effects of its inhibition. For 
this, we will use the antibody IST-9 (Abcam), which specifically targets the EDA domain of fibronectin, and 
peptides composed the EDA domain sequence ordered from a company producing custom peptide (i.e. 
Thermo Fisher). Both the antibody and the peptides will be used in serum starvation assays by being added 
in the culture medium at the concentration required by the product. If no recommended concentration is 
stated in the product’s specifications, we will perform titration assays to decide a working concentration. 
Signaling pathway inhibition assays 
To study the implication of different signaling pathways involved in serum starvation-induced dormancy, 
we will use small molecule inhibitors. To study ERK signaling, we will use the small molecule inhibitor 
FR180204 (Sigma-Aldrich); for the focal adhesion kinase (FAK), we will use FAK inhibitor 14 (Sigma-
Aldrich; and for the MAPK kinase (MEK), we will use  PD0325901 (Sigma-Aldrich).  
These inhibitors will be added to serum starvation assays to see how the inhibition of the different signaling 
pathways affects entrance into dormancy and cell survival. ERK, FAK, and MEK phosphorylation states 
using the antibodies listed in Table 4 to perform Western Blot analyses based on chemiluminescence. 
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Table 4. Commercial antibodies destined to the study of ERK, FAK, and MEK signaling pathway 
activation states using Western blot in different experiments throughout the project.  
Protein Primary antibody Secondary antibody 
ERK M5670, rabbit mAb 
(Sigma-Aldrich) 
Goat Anti-Mouse IgG Antibody HRP 
conjugate 
(Sigma-Aldrich) 
FAK SAB4502495, rabbit mAb 
(Sigma-Aldrich) 
MEK SAB4502404, rabbit mAb 
(Sigma-Aldrich) 
pERK  
(p-204) 
2D11, mouse mAb  
(Santa Cruz Biotechnology) 
Goat Anti-Rabbit IgG Antibody HRP 
conjugate 
(Sigma-Aldrich) 
pFAK 
(p-397) 
E-4, mouse mAb 
(Santa Cruz Biotechnology) 
pMEK 
(p-218/p-222) 
7E10, mouse mAb 
(Santa Cruz Biotechnology) 
Analysis of mRNA levels of fibronectin and integrins 
We will study the expression of different fibronectin splicing variants and integrins to gather expression 
profiles and use them to analyze the relevance of the different proteins on cell dormancy. For this, we will 
study the expression of the different genes listed in table 5 by RT-qPCR. For this, we will seed the 16 
different cell lines listed in table 2 at a density of 30,000 cells/cm2 in 24 well-plates with soft 2D culture 
substrates coated with PDL. Each cell will be cultured in triplicate. They will be cultured without serum in 
their respective culture mediums for 7 days, as this period should be enough for cells to adapt their 
expression pattern to the serum starvation condition. At this point, RNA will be extracted using the 
PicoPure™ RNA Isolation Kit (Thermo Fisher). Once extracted, the samples will be transferred to 96-well 
plates and the SYBR® Green Quantitative RT-qPCR Kit (Sigma-Aldrich) will be used to measure the 
expression of the target genes. GAPDH will be used as the control housekeeping gene. To study fibronectin 
alternative splicing, we will design exon-exclusive primers. 
Table 5. Target and control genes for the RT-qPCR analysis. This screen includes the different isoforms 
of fibronectin and different integrin subunits. Some integrin subunits have been selected given their ability 
to bind specifically the EDA+ motif, as explained in the “Integrin biology” section.  
Integrin α 
subunits 
Integrin β 
subunits 
Fibronectin splicing 
variants 
Housekeeping gene 
α1, α2, α3, α4, α5, 
α7, α9, αv 
β1, β2, β3, β5, β7 EDA+, EDB+, ED-, IIICS GAPDH 
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Integrin inhibition assays 
To study integrin adhesion inhibition in a heterodimer-specific manner we will use small molecule inhibitors 
such as AF1864 (inhibits α5β1; R&D Systems) and BIO 1211 (inhibits α4β1; Tocris Bioscience, Biokom) 
among others. There are no commercially available small molecule inhibitors of α4β7, an integrin of 
potential interest for our project, for what we will use Vedolizumab biosimilar monoclonal antibodies such 
as MAB10078 (R&D Systems). These inhibitors have been selected for integrins of interest given the studied 
literature, although the protein expression assays performed in the project may result in the finding of other 
integrins worthy of study. Were this the case, small molecule inhibitors or antibodies will be obtained and 
tested too. The different inhibitors or antibodies will be added to the culture medium of cells undergoing 
serum starvation assays in the required concentration. 
If we find an integrin with a probable role in dormancy through our screenings, but no dimer-specific 
inhibitors or antibodies can be acquired commercially, we will design a siRNA against its gene and transfect 
it to perform the integrin inhibition assays. However, the results obtained would have to be studied carefully, 
as this strategy necessarily targets the gene of either one or both of the subunits in the integrin dimer. This 
could potentially cause off-target effects by inhibiting the formation of other integrin dimers and affecting 
their signaling pathways.  
Micropatterning neuroblastoma on soft 2D substrates 
In this project, we will use micropatterning techniques to study the impact of intercellular forces and cluster 
size on NB dormancy and to compare the differential effects of EDA- and EDA+ Fn. To study intercellular 
forces and cluster size, we will use a microcontact printing method where we inlay an EDA+ Fn pattern of 
circles of varying sizes in a 2D soft PDMS substrate (Shen and Kam, 2008; fig. 4).  
This process starts with the fabrication of a silicon mold with the desired pattern using photolithography. 
This process requires specific training and equipment, for what a collaboration with a group with expertise 
would be of interest. If this was not a possibility, molds can be obtained from specialized companies. Once 
a mold is obtained, a PDMS mixture with a P:C ratio of 10:1 is poured on the mold and baked at 60 ºC for 
4 hours. Once cured and semi-rigid, the PDMS stamp is peeled from the mold and activated using UV-
ozone for 5 minutes. The stamp is then loaded with a coating solution of EDA+ Fn (50 µg/ml), and the 
excess is dried carefully using a technical paper wipe. The loaded stamp is then inverted and placed on top 
of a 2D PDMS culture substrate previously activated and exposed to the EDC/NHS crosslinking solution. 
The mold then is pressed lightly for the solution to be transferred to the culture substrate, and then retired. 
The micropatterned culture substrate is then washed thoroughly and repeatedly with PBS to remove protein 
solution and EDC/NHS (step not depicted in fig. 4). Once washed, the micropatterned substrates are ready 
for cell seeding and experimentation. 
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Figure 4. Schematic representation of the microcontact printing process utilized to create micropatterned 2D soft 
PDMS substrates with EDA+ Fn. For a clearer depiction, only a partial representation of the micropattern has 
been illustrated. An iteration of this pattern will be used, resulting in more spots on the pattern and reaching a total 
stamp size of 4 mm. Including bigger patterned circles for bigger cell clusters can be optional. A washing step 
between steps 5 and 6 has been excluded for a clearer process depiction.  
Figure 5. Schematic representation of the sequential microcontact printing process used to produce 2D soft 
PDMS substrates co-patterned with EDA- and EDA+ Fn. The numbers in the scheme stem from the 
numeration used in figure 4. Only a fraction of 1 mm of the stamp has been represented – the actual pattern 
would be repeated horizontally and elongated vertically to fill a 5 mm square stamp. A washing step between 
steps 5 and 6 has been excluded for a clearer process depiction.  
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To study the differential effects of EDA- Fn and EDA+ Fn, we will produce substrates with a combined 
micropattern in which both Fn isoforms are alternatively patterned. To do this, we will use a new mold with 
rectangular shapes and follow the same procedure to cast, load, and dry PDMS stamps above explained (Fig 
4: sections 1-4). In this case, we will produce two different stamps and coat one with EDA- Fn (50 µg/ml), 
and the other with EDA+ Fn (50 µg/ml). Then, the transferring process will be performed sequentially, 
first with one stamp and then the other inverted horizontally (Fig 5). After this, the micropatterned substrate 
will be washed repeatedly with PBS (step not depicted in fig. 5). Once washed, the substrate will be ready 
for cell seeding and experimentation. 
Fibroblast and CAF characterization 
To study fibroblast activation and differentiation in presence of EDA+ Fn and/or dormant neuroblastoma 
cells, we will utilize the Human Adrenal Fibroblast cell line (ScienCell) for cell cultures and co-cultures with 
NB cells. To assess the differentiation state towards the CAF phenotype, we will study the expression of 
αSMA using the 1A4 antibody for immunostainings (Thermo Fisher). Additionally, in some experiments 
we will study matrix metalloproteinase (MMP) expression. We will use the MMP Activity Assay kit (Abcam) 
to quantify MMP activity and the Human MMP Antibody Array (Abcam) to assess specific MMP 
expression.  
Neuroblastoma and fibroblast co-cultures 
To study the interaction between neuroblastoma cells and fibroblasts in the context of dormancy, we will 
perform co-cultures of these cell types and perform serum starvation assays. To study the possible role of 
fibroblasts during NB entrance and exit from dormancy we will use two different culture regimes.  
First, to evaluate if fibroblasts can contribute towards NB cells entrance into dormancy, we will seed a 
mixture of both HDC cells and Human Adrenal Fibroblasts in soft 2D substrates coated with PDL. They 
will be submitted to a serum starvation assay by culturing them without serum for 28 days, and then with 
serum for a 28-day recovery period. We have designated a longer recovery period to account for the 
timescale in which fibroblasts react to fibronectin, commence the activation and differentiation process, and 
start remodeling their ECM.  
Second, we will study if fibroblasts play a role in the recovery process after serum is added to the culture 
medium. Because fibroblasts will most possibly not survive the serum starvation period, we will first culture 
the HDC line under serum starvation for 28 days. At the end of this period, fibroblasts will be seeded at the 
time that serum is added to the culture medium again, starting a 28-day recovery period. 
In both regimes, three different numbers of fibroblasts will be seeded to choose the best initial density: 
5,000, 10,000, and 20,000 fibroblasts per well. With this, we hope to find an adequate number of fibroblasts 
so that this cell type can exert an effect over dormancy while not taking over the cell culture and outgrowing 
neuroblastoma cells. 
 
25 
 
Because the previously used cell quantification technique cannot discriminate between cell types, it is 
impractical for the scope of this co-culture-based experiment. For this, we will transfect the HDC cell line 
with a plasmid containing the GFP gene and the fibroblast line with mCherry. We will study both cell lines’ 
population density using cell sorting every 7 days. Additionally, we will use the sorted populations to study 
their expression profiles by performing an RT-qPCR for the genes listed in table 5 and several MMP genes, 
plus the αSMA gene for fibroblast populations. 
Among the different conditions and time points, we will select those exhibiting results of interest and 
perform a more in-depth analysis using immunostaining and fluorescence microscopy. We will study the 
distribution of EDA+ Fn in the ECM, as well as the location of those integrins found to correlate with 
EDA+ Fn-induced dormancy.  
EXPERIMENTAL DESIGN 
Objective 1 – Translation of the serum starvation-induced dormancy in vitro model to 
neuroblastoma 
First, we will fabricate 2D soft culture substrates and use them to validate the use of serum starvation as a 
model of neuroblastoma cell dormancy in vitro. We plan to use PDL-coated 2D substrates of 1 kPa stiffness 
to conduct a first dormancy screening by culturing the 16 NB cell lines under serum starvation conditions. 
We will determine cell proliferation by using the PicogreenTM technique and analyze cell cycle using flow 
cytometry at the different time points of the assay (day 0, 7, 28, and 28 + 7 days recovery). To implement 
positive and negative controls, breast cancer cell lines HCC 1954 and HCC 202 will be used, for they present 
high and low ability to enter dormancy, respectively. Each condition will be run in triplicate using 24-well 
plates will be used in this screening. Based on the results obtained, we will assess each cell line’s ability to 
enter dormancy.  
Additionally, and in parallel with the first starvation assay, we will perform anti-Fn immunostaining on all 
16 NB cell lines plus two controls cultured for 28 days without serum. We will use two different antibodies, 
one against the constant region of Fn (EP5) and one against the EDA+ domain (IST-9). With this, we aim 
to preliminarily assess whether the presence of Fn and EDA+ Fn is also associated with dormancy. 
To study the effect of the ECM over dormancy, an EDA+ Fn-expressing NB cell line with prominent ability 
to enter cell dormancy will be used to produce decellularized matrixes. A second serum starvation screening 
will be performed using decellularized matrixes of HDC cell cultures and using only the 7-day serum 
starvation condition. Because the cell lines will be seeded on a dormancy-inducing, EDA+ Fn-containing 
matrix the cells do not need an ECM-remodeling and adaptation period.  
We will also study how ECM stiffness affects neuroblastoma cell dormancy by seeding HDC in 2D 
substrates coated with PDL of an elastic modulus of 0.1, 1, 50, 300, and 1000 kPa. We will analyze cell 
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proliferation and cell cycle to assess the impact of stiffness over dormancy. Besides, we will also evaluate if 
the dimensionality of the cell culture substrate affects dormancy. For this, we will seed the HDC cell line in 
silk-based, PDL-coated 3D culture substrates and submit it to a serum starvation assay. The number of cells 
seeded will be the same as in the first serum starvation assay, and the proliferation rates of both will be 
compared.  
Finally, we will analyze ERK, FAK, and MEK signaling in dormancy by performing a Western blot analysis 
after performing a serum starvation assay on a subset of three cell lines with high, medium, and low ability 
to enter cell dormancy. 
Expected results 
We hope to find that our set of selected NB cell lines exhibits varying capacities to enter cell dormancy and 
to survive in our first serum starvation screening. Optimally, we would find a cell line with a high survival 
rate (i.e. the HDC line) whose decellularized matrix, produced during 28 days of serum starvation, contains 
EDA+ fibronectin and is capable of inducing dormancy in some of the cell lines of the second serum 
starvation assay. We also expect that dormancy will be affected by the stiffness of the substrate, since harder 
stiffnesses induce NB cell differentiation in a process which could potentially alter the cell’s ability to enter 
dormancy. Among the different signaling pathways studied, we expect that ERK will be upregulated in 
dormant cultures, as previously described by Barney et al (2020). 
Contingency plan 
Although we hypothesize that serum starvation-induced cell dormancy will occur in cell lines of a wide 
variety of cancer types, it is possible that none of the selected NB cell lines is capable of fibronectin-
dependent cell dormancy. If this is found to be true, it would imply the failure of objective 1 because the 
serum-starvation in vitro model would not be of use to study dormancy in neuroblastoma. This would 
hinder the possibility of investigating Fn-dependent dormancy in neuroblastoma. However, if this scenario 
were to be faced, objectives 2 and 3 could still be pursued in their totality using the breast cancer cell lines 
described by Barney et al. (2020) and modifying some of the protocols.  
Objective 2 – Studying the relevance of the EDA domain of fibronectin in neuroblastoma 
cell dormancy 
To evaluate if the EDA domain does have a crucial role in cell dormancy, we will utilize the HDC line to 
perform a series of serum starvation assays under different conditions. First, we will perform a serum 
starvation assay using different 2D soft substrates: PDL-coated, decellularized matrixes, pFn-coated, and 
EDA+ Fn-coated. We will perform a second assay in EDA+ Fn-coated substrates where we test how adding 
the IST-9 antibody (anti-EDA) or the EDA peptide in the culture medium affects cell dormancy. In this 
second assay, we will also analyze survival rates and ERK, MEK, and FAK phosphorylation states. We will 
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finally perform a third assay where we will study how the shutdown of ERK, MEK, and FAK signaling 
pathways affect cell dormancy using small molecule inhibitors.  
To gain a deeper understanding of the gene expression profile of the different cell lines and how it affects 
their ability to enter dormancy, we will study the integrin expression pattern and the fibronectin splicing 
profile of the different cell lines. We will use these results to evaluate which integrins are linked to dormancy 
and further study their role by implementing integrin inhibition assays.  
Finally, we will use the micropatterned substrates with circular patterns of varying sizes to study the 
relevance of cell cluster size and intracellular tension over dormancy using HDC cells. Additionally, we will 
use the substrates micropatterned sequentially EDA- Fn and EDA+ Fn to study if HDC cells have a 
differential affinity for these substrates under normal conditions or under serum starvation.  
Expected results 
We expect to find, as our hypothesis states, that the EDA+ domain is necessary for the dormancy-inducing 
effect of TCFn. We believe that we will find how cell populations seeded in EDA+ Fn substrates exhibit 
higher proportions of dormant cells than those exposed to EDA inhibitors or those seeded in pFn. We 
hope to find specific integrins (possibly α4β7) that are linked to dormancy and implicated in the transduction 
of EDA+ Fn signaling into the cell. We also expect to find that cell cluster size and intercellular tension will 
positively affect EDA+ Fn-dependent dormancy. Similarly, we expect to find that cells grown on 
sequentially patterned substrates survive only in the areas coated with EDA+ Fn, possibly influencing cell 
migration when under serum starvation.  
Contingency plan 
Although we expect that at least one of the cellular fibronectins commercialized by the companies ScienCell 
and Sigma-Aldrich will contain the EDA domain, none of them has tested this. In case we found that none 
of the products contains the EDA domain, it would be necessary to generate a cell line destined for EDA+ 
Fn production to express and purify the protein. It is also a possibility that we fail to find integrins whose 
expression correlates with dormancy. If this happened, it would not be possible to perform the integrin 
inhibition assays. Conversely, we may find a specific integrin that is linked to dormancy for which no 
commercial antibodies or inhibitors exist. If this were to happen, we would use siRNAs to perform gene 
knockdown studies. On a different note, it is possible that substrates coated with EDA+ Fn do not induce 
dormancy as decellularized matrixes containing fibronectin have been shown to do. If this were the case, 
the microcontact printing methods could not utilize this protein and would require the testing of other 
molecules such as PDL or possibly pFn.  
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Objective 3 – Evaluating the effects of EDA+ fibronectin over stromal fibroblast 
populations 
To study the possible effect that EDA+ Fn secreted by dormant neuroblastoma cells could have over the 
fibroblasts found in the tumor stroma, we will utilize an adrenal fibroblast cell line. First, we will assess 
whether seeding the fibroblasts in different substrates affects fibroblast activation and differentiation 
TGFβ1 is added to the culture medium. For this, we will seed fibroblasts in 2D soft PDMS substrates of 
the following kinds: PDL-coated, HDC decellularized matrixes, EDA+ Fn-coated, and pFn-coated. We will 
culture them with or without TGFβ1, and we will study differentiation towards the CAF phenotype by 
studying αSMA and MMP expression. Second, we will study how the blocking of EDA and/or the TGFβ 
receptor affects fibroblast differentiation when incubated in EDA+ Fn-coated 2D substrates in the presence 
and absence of TGFβ1.  
To observe and evaluate the direct interactions between dormant neuroblastoma cells and fibroblasts, we 
will use the described co-culture system. We will study how fibroblasts interact with NB cells in the entrance 
into dormancy and during exit and recovery. To better fit the fibroblast differentiation and ECM remodeling 
process timescales, we will use recovery periods of 28 days instead of 7 days. We will use cell sorting 
technologies together with RT-qPCR to study the genic expression of fibronectin isoforms, integrins, and 
MMPs at different time points, as well as αSMA, to track fibroblast differentiation. Complementarily, we 
will use immunostainings and fluorescence microscopy to image the ECM in those time points of interest, 
carefully studying possible interactions between Fn and integrins and MMP expression. 
Expected results 
We expect to find that TGFβ1-induced fibroblast activation and differentiation is dependent on the 
substrate that the fibroblasts are cultured on. We expect that fibroblasts seeded in decellularized matrixes 
and EDA+ Fn-coated substrates will be more active: a higher proportion of the fibroblasts in the culture 
would then be transitioning to the CAF phenotype and expressing the specific marker αSMA. We also 
predict that this behavior will be reverted by adding the IST-9 antibody or the EDA peptide to the culture 
medium, confirming the relevance of the EDA domain in CAF differentiation. Lastly, from our co-culture 
experiments we hope to find that when the HDC line is cultured under serum starvation, it is capable of 
inducing fibroblast activation. We believe that while EDA+ Fn expression may be increased in the short 
term, it could be degraded and replaced with other ECM components in the long term, leaving no trace of 
its relevance in NB cell dormancy. 
Contingency plan 
The experiments proposed for this objective are end-point studies with no other experiments depending on 
their results. Whether their results correspond to our expected results or not, they will provide valuable 
information for the goals of the study. However, some of the experiments could be modified to avoid any 
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problems that could arise. For example, the NB-fibroblast cocultures under serum starvation could fail to 
activate fibroblast differentiation because none of the cell types express TGFβ1 in these conditions. If this 
happened, the experiment could be repeated adding exogenous TGFβ1 to promote differentiation and 
assess how this molecule would affect the interactions between both cell types in a pro-fibrotic and pro-
inflammatory molecular context. 
Chronogram 
Table 6. Chronogram depicting the 3-year schedule planned for this project.  
DISCUSSION 
Understanding the mechanisms underlying cancer relapse is one of the open frontiers in oncology. Because 
neuroblastoma is a pediatric tumor where relapse is not only frequent but usually lethal, reaching this goal 
is especially important. Not only to reduce the mortality associated with this type of cancer but especially 
because neuroblastoma relapse tends to occur in the first decade of life, severely truncating the life 
expectancy of those with this condition (Modak and Cheung, 2010). For this, we believe that understanding 
the mechanisms driving NB relapse is key to obtain a better understanding of this detrimental process. By 
knowing the causes of relapse, new therapies targeted towards it could arise and significantly improve the 
outcome of neuroblastoma patients. 
Cancer cell dormancy is widely considered to be one of the biological processes contributing to relapse. 
While it remains unclear how cells enter and exit the dormant state, there is growing evidence pointing 
towards the role of the ECM in the regulation of this process. More specifically, fibronectin has been directly 
linked to dormancy in at least two different types of cancer (Aguirre-Ghiso et al., 2017; Barney et al., 2020). 
For these reasons we believe that a project investigating whether fibronectin plays a role too in 
neuroblastoma dormancy and relapse is highly interesting.  
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From a more biological point of view, we have pointed out the importance of fibronectin alternative splicing 
regarding the EDA domain. It is doubtlessly relevant in processes related to tumor progression such as CAF 
differentiation and, as previously mentioned, may enable fibronectin to induce dormancy. With the methods 
and experiments proposed, we hope to shine light on the latter issue and to verify whether this domain is 
necessary for Fn-induced cancer cell dormancy.  
We also expect to find that EDA-containing fibronectin will not only enable NB dormancy and survival 
over extended periods of adverse conditions but also drive CAF differentiation. An interesting feature of 
fibronectin-dependent cell dormancy is that the Fn-rich matrix produced during the dormant state needs to 
be degraded for cells to exit it. The differentiation of fibroblasts towards the CAF phenotype would certainly 
contribute to this degradation, acting as a key accomplice for tumor cells by starting a deep ECM remodeling 
process. This way, NB and CAFs could potentially collaborate to produce a microenvironment that 
promotes tumor progression and growth.  
Interestingly, the mechanism we propose could enable cells to survive harsh conditions such as 
chemotherapy and to recover once these have passed in an untraceable manner. Once a population of 
dormant NB cells exits dormancy and reorganizes its ECM composition with help of newly activated CAFs, 
it needs to degrade the same matrix that enabled its survival. This would strictly narrow the spatial and 
temporal window in which EDA+ fibronectin can be detected, allowing this hypothetical mechanism to 
remain unobserved and unknown. This possibility further highlights the need for the development of an in 
vitro model for neuroblastoma cell dormancy.  
All of the above strengthens the importance of meeting our three specific aims; to generate a preclinical in 
vitro model of cell dormancy for neuroblastoma; to study the possible role of fibronectin, and specifically 
its EDA+ isoform on NB cell dormancy; and to investigate the potential contribution of this protein 
towards CAF activation and differentiation. 
In the future, the neuroblastoma dormancy model developed for this study could be used to screen drug 
libraries for compounds capable of inhibiting entrance and exit from dormancy. Drugs capable of doing so 
could potentially be used as a combined treatment with or after chemotherapy to combat minimal residual 
disease more efficaciously, therefore minimizing relapse frequency.  
Additionally, we would like to point out the relevance of the EDB-containing isoform of fibronectin. Our 
study, once completed, could be followed up by investigating the role of the alternatively spliced EDB 
domain over tumoral angiogenic and vasculogenic processes. Neuroblastoma is a highly vascularized tumor 
that can induction the creation of new blood vessels utilizing several different mechanisms, some of which 
are still not well understood.  
Concluding, we believe that our proposed hypothesis and project are in line with the latest findings regarding 
the role of the ECM in cancer cell dormancy. We also believe that if this investigation is fruitful, it would 
represent a crucial piece of knowledge towards the fight against relapse in neuroblastoma. The validation of 
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our hypothesis would be a very relevant contribution towards our understanding of NB dormancy, 
chemoresistance, and relapse, topics of utmost importance in pediatric oncology. 
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Practical case 1 
Extracellular matrix rigidity modulates neuroblastoma cell 
differentiation and N-myc expression 
Lam, W. A., Cao, L., Umesh, V., Keung, A. J., Sen, S., & Kumar, S. (2010). 
Molecular Cancer, 9(1), 35. https://doi.org/10.1186/1476-4598-9-35 
1. What is the biological and/or clinical question that the article seeks to answer? 
In the article, previous findings are noted (19, 22-30) showing how ECM stiffness and other biophysical 
properties of it have direct influence over neuroblastoma stem cell differentiation, neuronal maturation, 
neurite growth and extension, malignancy, and tumoral phenotype, and also how the signalling pathways 
influenced by ECM stiffness coincide, at least partially, with those of retinoic acid (RA) induced 
differentiation. Thus, the biological question the authors propose and try to answer is: 
Do mechanical cues from the ECM influence spontaneous neuroblastoma differentiation, and if so, do they 
share signalling pathways with retinoic acid? 
2. What is the working hypothesis? 
To answer the questions the following hypothesis was proposed: mechanical cues from the ECM have an 
impact on neuroblastoma, affecting spontaneous and RA-induced differentiation, as well as altering its 
phenotype in means of clinically relevant and markers of proliferation and differentiation. 
3. What does this article show? Is it of utility in the short or long term? What kind of 
work is it (Basic science, molecular biology mechanism, method, or device 
development)?  
The study evidences how ECM stiffness, a simple biophysical parameter, is able to exert changes in 
biological markers of differentiation and proliferation of clinical relevance in neuroblastoma prognosis. 
They also show how this signalling acts synergistically with RA in the induction of differentiation. 
It’s a basic science article with a clear short and mid-term utility: the effect that surface culture rigidity exerts 
on neuroblastoma cells may also affect other cells, altering the results obtained in experiments studying 
differentiation and proliferation effects of pharmaceuticals, for example.  
4. What are the critical experiments and principal methods utilized to answer the 
biological/clinical questions and confirm (or not) the working hypothesis? 
1. Culturing of SK-N-DZ cells on collagen I-laminated polyacrylamide (PA) gels of stiffnesses varying 
from 0.01 kPa to 10000 kPa, both in absence and presence of RA. Measurements: neurite length. 
2. Ki67 (proliferative marker) immunostaining of SK-N-DZ cells cultured on two different stiffnesses 
(0.1 kPa and 1000 kPa), both in absence and presence of RA. Measurements: Ki67 
immunofluorescence. 
3. WST-1 (metabolic activity reporter) staining of SK-N-DZ cells cultured on three different 
stiffnesses (1 kPa, 50 kPa, and 300 kPa), both in absence and presence of RA. Measurements: WST-
1 absorbance. 
4. RT-PCR quantification of N-myc expression in SK-N-DZ cells cultured on two different 
stiffnesses (1 kPa and 300 kPa). Measurements: N-myc relative expression. 
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5. Identify the controls used in the experiments and explain their utility or function 
for the analysis of the results. 
Given the nature of the experiments performed, the definition of a control is slightly difficult – when the 
effect of surface rigidity is studied, all surfaces will have a determinate, discrete rigidity which will affect cell 
behaviour, making the implementation of a “negative control” impossible.  
The use of glass in the first experiment could be deemed a control, since it is a standard surface for cell 
culture with which the researchers can use to compare how the cells behave in the PA gels vs. a common 
culture surface. However, when it comes to quantification and measurements of the effect that surface 
rigidity exerts over neuroblastoma differentiation and proliferation, it should be taken as another point in 
the studied range of stiffnesses, and not a standard, “outsider” control. 
The rest of experiments do not present controls, since both the absence of RA and its presence are 
conditions of study, and thus not controlled measurements to be used as reference. 
6. What are the conclusions? 
The authors conclude that their hypothesis has been proved right, that surface rigidity by itself can directly 
alter neuroblastoma differentiation and proliferation, as well as biomarkers of clinical interest such as N-
myc.  
7. Do you believe that the experiments and the interpretation of the results are 
adequate to answer the biological/clinical questions and confirm (or not) the 
working hypothesis? 
I believe the performed experiments are well based, conducted, and interpreted in order to answer the 
biological question, but I believe more could have been done to prove the answer. Using only neurite length 
and N-myc expression decay as differentiation markers may fall short of what was possible to do for testing 
and proving differentiation, since other relevant biomarkers could remain unaltered. Further experiments 
could strengthen the claim.  
8. Do you believe that the results are well interpreted and that the conclusions are 
well-founded? 
I believe that the results are well interpreted, and that the conclusions are well funded, but as just stated, 
they could have been supported with more data and experiments. 
9. Is the working hypothesis confirmed to a 100% with the obtained results? 
Almost 100%, yes, but as stated in answers 7 and 8, it could be more solid. 
10. Write a critical analysis of the article stating its strong and weak points   
The article describes a novel factor that can promote differentiation of neuroblastoma cells, and most 
importantly, describes a purely mechanical one. For decades biophysical factors have been completely 
overlooked, being biochemical cues the ones thought to produce most, if not all, changes in cellular biology. 
This work, as others have done before it, describes a key process by which most preclinical research is 
involved: the own rigidity of the culture plaques and flasks can cause changes in cell differentiation and 
proliferation. If this process is overlooked, assays testing pharmacological compounds or novel therapies 
will fail to properly show the effect these therapies have, as stiffness-induced differentiation will happen as 
an artefact, distorting the results. With very simple experiments, the authors have been able to describe a 
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process which may concern to all researchers of the field. The use of “classical” culturing surfaces such as 
glass and plastic may bias results.  
On the downside, the simplicity of the experiments may at the same time take a bit of strength off the 
claims of the researchers. 
11. What experiments do you believe should have been performed to improve the 
article and make the conclusions more robust? 
In the first place, and after the first experiment results were observed, I would choose two determinate 
stiffnesses, a low one where differentiation should not occur and a high one where it should, and culture 
them with different concentrations of RA. Retinoic acid, a known pro-differentiating agent, would allow 
me to observe the effects that RA exerts over the cells in terms of proliferation and differentiation, as to 
have a sort of control experiment with which I could compare the results obtained with the alteration of 
surface rigidity.  
Then, later in time, maybe in parallel with experiments 3 and 4 where differentiation and proliferation are 
assessed, I would perform experiments to study the differentiation process more closely, by using immature 
and mature neuronal markers like doublecortin and NeuN. With these experiments, I would expect to see 
the same results as with previous ones (i.e. neuroblastoma cells differentiate), only with more “resolution 
power” on the process. 
12. Suggest a different working hypothesis based in the same biological/clinical 
question posed in this article 
Two separate hypotheses are proposed to not surrender individual success of any of them to the other, 
although they could be combined, as they will in the abstract on question 14. 
1. Mechanical cues from the extracellular matrix affect neuroblastoma cell differentiation and 
proliferation in irreversibly.  
2. Mechanical cues from the extracellular matrix affect cellular differentiation and proliferation in 
different cell types.  
13. What would be the critical experiments that you would need to perform to confirm 
(or deny) the hypothesis that you have proposed in question 12? What controls 
would be needed? 
In order to test the first hypothesis, I would use the two following experiments – the first to track behaviour 
over time, the second to check the effect of a change in the stiffness the cells are cultured on. 
a. Culturing of SK-N-DZ cells on 3 different stiffnesses (0.1, 50, and 300 kPa), one in each range set 
in experiment number 1. Measurement of neurite length and Ki67 immunostaining in timepoints 
0, 1, 2, 3 and 4 weeks.  
b. Culturing of SK-N-DZ cells on 3 different stiffnesses (0.1, 30, and 300 kPa). After 3 days, the 
culturing period of the original article, cells from each stiffness will be harvested and split in 3 
cultures of 0.1, 50, and 300 kPa stiffnesses, being cultured for another 3 days. Measurement of 
neurite length and Ki67 immunostaining of all 9 cultures.  
To test the second hypothesis, I would repeat the experiments 2 and 3 performed in the original article for 
the results obtained to be comparable to SK-N-DZ. Experiments 1 and 4 are neuroblastoma specific 
(neurite outgrowth and N-myc expression measurement), so they need to be adapted. I would test a 
multipotent stem cell line, more specifically a mesenchymal stem cell (MSC) line, which would for sure be 
of interest when testing the effect of surface stiffness. Mesenchymal stem cells can differentiate into 
osteoblasts, chondrocytes, and adipocytes, three cell types which inhabit very different environments with 
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three very different stiffness which could account for their differentiation processes. In order to assess their 
grade of differentiation, as done in experiments 1 and 4 in the original paper, I would qualitatively study 
their morphology and behaviour to try to discern if there’s differentiation to any MSC-derived cell type. If 
these qualitative parameters were to show differentiation processes, I would attempt to use 
immunofluorescence against markers of the cell type that the MSCs have differentiated to.  
14. Design a graphical abstract for the hypothetical article that your proposed 
hypothesis and experiments would yield. 
 
 
  
6 
 
Practical case 2 
Patterning microscale extracellular matrices to study 
endothelial and cancer cell interactions in vitro  
Dickinson, L. E., Lütgebaucks, C., Lewis, D. M., & Gerecht, S. (2012). 
Lab on a Chip, 12(21), 4244. https://doi.org/10.1039/c2lc40819h 
1. What is the biological and/or clinical question that the article seeks to answer? 
The article, being a technical paper, answers a technical question rather than a biological one: 
Can we produce a spatially controlled cell co-culture system with which to study interactions between cancer 
cells (BCCs) and endothelial cells (ECFCs), and among these cells and the composition of the extracellular 
matrix (ECM)? 
2. What is the working hypothesis?  
Again, taking the nature of the paper into account, the question might need a small twist. In this article they 
test a technical design (two, actually) rather than a hypothesis.  
1. The design consisting of sequentially patterned fibronectin (Fn) and hyaluronic acid (HA) will allow 
for the discrete and spatially controlled co-culture of ECFCs and BCCs, each growing respectively 
in one of the patterned molecules.  
2. The design consisting of a combination of 2D patterning of Fn for ECFCs and encapsulation of 
BCCs in micromolded HA hydrogels will allow for the discrete and spatially controlled co-culture 
of ECFCs and BCCs. 
However, they do present a minor biological hypothesis which, while not the basis of the study, is the base 
of the first design: they hope that BCCs will specifically bind to HA, while ECFCs will specifically bind to 
Fn. This proves to be wrong as BCCs do not bind only HA but are actually capable of binding Fn and even 
PEGylated surfaces.   
3. What does this article show? Is it of utility in the short or long term? What kind of 
work is it (Basic science, molecular biology mechanism, method, or device 
development)?  
This work demonstrates the capacity of the second co-culturing method for the study of cell-cell and cell-
ECM interactions in a spatially and biochemically controlled manner. It presents a powerful tool for the 
study of how tumour cells interact with endothelial cells, taking also into account the composition of the 
ECM.  
The article is, as previously mentioned, a methodological or technical paper. 
4. What are the critical experiments and principal methods utilized to answer the 
biological/clinical questions and confirm (or not) the working hypothesis?  
1. Surface co-patterning of fibronectin and hyaluronic acid using microcontact printing and silane 
chemistry (OTS and APTMS respectively). Measurements: immunofluorescence measuring of Fn 
and HA intensity and spatial disposition on the surface after the process.  
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2. Culturing of ECFCs on Fn-HA patterned substrates. Control: culture in Fn-Collagen I patterned 
substrates (no preference expected). Measurements: bright field and fluorescent microscopy 
observation of cell location. 
3. Culturing of three different BCC lines; nontumorigenic MCF10A; tumorigenic, non-metastatic 
MCF7; and metastatic MDA-MB-231; on the Fn-HA patterned surfaces. Measurements: bright 
field and fluorescent microscopy observation of cell location. 
4. Co-culture of ECFCs and the three different BCC lines on Fn-HA patterned surfaces. 
Measurements: bright field and fluorescent microscopy observation of cell location. 
5. Encapsulation of the three BCC lines in HA hydrogels. Measurements: cell survival rate at days 0, 
1, and 3. 
6. Encapsulation of BCC cell line MDA-MB-231 in micromolded HA hydrogels. Control: culture in 
standard conditions. Measurements: Ki67 immunostaining. 
7. Co-culture of encapsulated MDA-MB-231 cells in HA micromolded hydrogels in contact with 
ECFCs cultured in 2D-patterned Fn. Measurements: bright field and fluorescent microscopy 
observation of cell location.  
5. Identify the controls used in the experiments and explain their utility or function 
for the analysis of the results.  
Experiments 2 and 6 present controls. In experiment 2, a control is used where ECFCs are cultured in Fn-
Collagen I patterned substrates. It was previously known that ECFCs show no preference between Fn and 
collagen I molecules in terms of adhesion, and that they would grow in both when co-patterned. They used 
this knowledge to compare how ECFCs behave once they are placed in Fn-HA patterned surfaces, where 
a differential adhesion is expected.  
In experiment 6, standard culture conditions are used as a control in the assessment of BCC proliferation 
using the measurement of Ki67 immunofluorescence. This control is compared with BCCs encapsulated 
in HA matrixes to assess whether the cells’ proliferative capacity was diminished when embedded in HA.  
6. What are the conclusions?  
Authors conclude that BCCs do not specifically attach and adhere to HA, rendering the first co-culture 
technical design failed. They also conclude that when using the combined HA micromolding and Fn 
patterning co-culture method, BCCs and ECFCs are contained in their spaces, allowing for a 
stereoscopically controlled study of their interactions.  
7. Do you believe that the experiments and the interpretation of the results are 
adequate to answer the biological/clinical questions and confirm (or not) the 
working hypothesis?  
There’s an ample set of experiments supporting their claims. It must be noted how the authors even 
published negative results (i.e. their first design not working), showing the evidence for it. The expermients 
seem adequate to answer their questions, as they’re fairly simple and can be answered with the sole location 
and attachment preference of the cultured cells.  
8. Do you believe that the results are well interpreted and that the conclusions are 
well-founded?  
Yes, I believe the claims are fair and the conclusions well based. If an objection can be proposed, it would 
be against the time period in which the cells remain where originally designed, as in their second method 
ECFCs are only contained in the Fn pattern for 24 hours, time after which they replace the Fn with their 
own ECM as BCCs will eventually do too. This limits experiments to 24 hours unless ECFC migration can 
be overlooked for the purpose of one’s experiment, reducing the utility of the co-culture method.   
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9. Is the working hypothesis confirmed to a 100% with the obtained results?  
Following the answer to question number 2, I would say that the second co-culture method has been 
properly validated. The first design would also have been properly invalidated.  
10. Write a critical analysis of the article stating its strong and weak points.  
The authors show two methods with great potential to study cell-cell interactions in a spatially controlled 
manner. As a note, even though the first design may have not worked with BCCs and HA, other ECM 
components could work for other cell types. The second study is doubtlessly a powerful tool to study how 
cancer cells can interact and affect the cells in their environment. Even if the cells and polymers used in 
their example are limited to 24 hour studies, this could be enough time to see interesting results, and, as in 
the first method, other cells and polymers could possibly be used with much longer and more adequate 
culture times.  
11. What experiments do you believe should have been performed to improve the 
article and make the conclusions more robust?  
I believe that the experiments performed and reported are well suited to back their claims and conclusions, 
and in that sense, I would not perform any experiments. I would, however, add experiments aimed at 
expanding the knowledge and utility resulting from the work.  
In experiment 7, ECFCs and BCCs need different time periods to break through their designated location 
on the combined method co-culture (24 and 48 hours respectively). After seeing the results of experiments 
3 and 4, where BCCs migration and survival are clearly not restricted by the molecule which they bind, it 
would be logic to question whether the encapsulation process itself is the one responsible for holding these 
cells for longer (48h) than the Fn patterned ECFCs.  
I would propose a third technical design based on the hypothesis that containment time in the 7th 
experiment stems from the technique used to pattern the cells rather than from the molecule used to pattern 
them.  
Being ECFCs (cultured on a 2D Fn-patterned surface) the cells with the shorter containment time, this 
third technical design would be fully based on the alternative micromolding technique. This way I’d be able 
to compare this design with the second one from the original article, allowing me to see whether this 
difference stems from the way in which cells have been set “in place” (i.e. by using a 2D pattern vs. 
embedding them on a hydrogel), or from the molecule which theoretically does this (Fn and HA). 
I would thus develop a method to distribute the micromolded HA and Fn patterns by designing a mold 
allowing for the sequential deployment of the micromolded hydrogels in the desired distribution. In case 
this wasn’t possible, an approach similar to that in the original second technical design could be used, where 
two surfaces are laden with the micromolded HA/Fn and the embedded BCCs and ECFCs respectively, to 
later be put in contact by inverting one in top of the other. 
I would finally repeat the observations in experiment number 7 (cell location and ECM degradation over 
48 hours at least, going up to 72h) in this third setting.  
12. Suggest a different working hypothesis based in the same biological/clinical 
question posed in this article. 
The authors mention in the conclusions how this co-culture method could potentially be used with most 
cell types. This would doubtlessly be an interesting model for studying neuroblastoma (NB) vasculogenesis, 
given that this kind of tumour is frequently highly vascularized. This model could possibly enable us to 
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study the way in which cells in the outer layers of a tumour, where most vessels are formed by “host” cells 
and not tumour endothelial cells (TECs) interact with.  
I would thus present the hypothesis that the second co-culture method developed in the article can be used 
too with neuroblastoma cell lines, becoming a new preclinical model for the study of vasculogenesis in NB. 
13. What would be the critical experiments that you would need to perform to confirm 
(or deny) the hypothesis that you have proposed in question 12? What controls 
would be needed?  
In order to assess whether the second co-culture method designed by the researchers could be adapted to 
neuroblastoma studies, I would first perform experiment 5 using a three distinct NB cell lines showing the 
characteristics that the BCCs did in the original article (a non-malignant line; a malignant, non-metastatic 
line; and a metastatic line). Once their viability and proliferation rate are well described, I would choose the 
most suitable line (that with higher viability and proliferation rates) and perform experiments 6 and 7. With 
the results, I’d expect to see that NB cell lines behave similarly as the BCC cell lines, staying in their 
micromolded matrixes for long enough to study their interactions with ECFCs. As a control, the cell lines 
used in the paper could be used in all 3 experiments.  
This model could then potentially be used to test pharmaceuticals which block vascularization induction in 
normal cells, to see if impairing common vasculogenic pathways inhibits the interactions between NB cells 
and ECFCs,  or to test different conditions shown to drive TEC differentiation, such as hypoxia, to see 
what role normal ECs would play in such an environment. 
14. Design a graphical abstract for the hypothetical article that your proposed 
hypothesis and experiments would yield. 
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Practical case 3 
A Photoactivatable Nanopatterned Substrate for Analyzing 
Collective Cell Migration with Precisely Tuned Cell -
Extracellular Matrix Ligand Interactions 
Shimizu, Y., Boehm, H., Yamaguchi, K., Spatz, J. P., & Nakanishi, J. (2014). 
PLoS ONE, 9(3), e91875. https://doi.org/10.1371/journal.pone.0091875 
1. What is the biological and/or clinical question that the article seeks to answer?? 
The question which the authors aim to answer would be as follows: Does extracellular matrix (ECM) 
geometry affect the individual/collective behaviour of cell migration? 
2. What is the working hypothesis?  
The researchers propose the following hypothesis: The use of substrates with spatially and geometrically 
well-defined cell-adhesive ligands affects the collectiveness of HeLa cell migration. 
3. What does this article show? Is it of utility in the short or long term? What kind of 
work is it (Basic science, molecular biology mechanism, method, or device 
development)?  
This work describes a novel culture substrate for studying cell migration in a spatially, geometrically, and 
biochemically controlled setting, at the same time that it describes how this substrate affects FAK 
phosphorylation and function, ultimately altering migration profiles of HeLa cells. It is an article which 
combines the description of a new technical development with a basic science discovery. 
4. What are the critical experiments and principal methods utilized to answer the 
biological/clinical questions and confirm (or not) the working hypothesis?  
1. Nano-patterned photoactivatable substrate preparation and validation using gold-thiol and silane 
chemistries and testing before and after UV photoactivation. Measurements: scanning electron 
microscopy imaging of UV-irradiated and non-irradiated surfaces. 
2. Seeding of HeLa cells in nano-patterned photoactivatable substrates (NPS) irradiated with UV in 
varying intensities (between 0 and 10 J/cm2). Measurements: Optical microscopy for the 
assessment of adhered cell numbers.  
3. SEM imaging of HeLa cells on the nano-patterned photoactivated substrate. 
4. Seeding of HeLa cells in photopatterned stripes in NPS. Control: Seeding of HeLa cells in 
photopatterned NPS with only PEG12K functionalization (no cRGD, no adherence expected). 
Measurements: Assessment of cell location with optical microscopy. 
5. Seeding of HeLa cells in photopatterned circles (150 µm diameter) in NPS, with a second 
irradiation after 9h for the induction of cell migration. Control: Seeding of HeLa cells in 
photoactivatable homogeneous gold surfaces. Measurements: time-lapse microscopy imaging over 
a 9-hour period. 
6. Seeding of HeLa cells in photopatterned circles (150 µm diameter) in NPS, with a second 
irradiation after 9h for the induction of cell migration. 3 hours after induction, cells were fixed for 
immunostaining. Control: same experiment in homogeneous surfaces. Measurements: fluorescence 
microscopy of fixed cells immunostained for N-cadherin, F-actin, and vinculin. 
11 
 
7. In silico analysis of cell migration behaviour based on the time-lapse movies taken in experiment 
number 5. Measurements: cell morphology over time, cell migration tracking, individual cell 
migration rates, directional persistence of individual cell migration.  
8. Seeding of HeLa cells following the same proceeding as in experiment number 6. Measurements: 
fluorescence microscopy of fixed cells immunostained for FAK, pY379 FAK and pY861 FAK. 
5. Identify the controls used in the experiments and explain their utility or function 
for the analysis of the results.  
Several controls are used in most of the experiments in order to compare how the cells behave in the NPS 
compared to other surfaces. Experiments 4, 5, 6, and 8 have controls.  
 Experiment 4 
In the control, cells are seeded in a substrate which has been photopatterned just like the normal one, but 
in this case, the substrate does not have cRGD, so after photoactivation (and thus cleaving of the only 
functionalizing molecule PEG12K) the nude gold should be exposed, rendering the whole substrate, 
photoactivated or not, non-adhesive.  
The control thus allows the researchers to see if and how the cells adhere in the normal NPS, in comparison 
to a similar substrate which has undergone the same photoactivation process but is not adhesive. 
 Experiments 5, 6 and 8 
Cells are seeded both in the normal NPS and in a control substrate which is homogeneously laden with the 
gold nanoparticles and thus also homogeneously functionalized with PEG12K and cRGD. This control is 
used in these three experiments studying cell migration after the release of cells from their confinement in 
the 150 µm circles through photoactivation.  
These controls are essential to see how a nanoscopically defined adhesion ligand geometry influences cell 
migration versus a normal, homogeneous surface.  
6. What are the conclusions?  
The authors conclude that their hypothesis is valid, and that the use of their NPS alone is enough to alter 
the manner in which HeLa cells migrate: they do so in an independent, individual manner when in the 
nano-patterned surface, but migrate collectively in the homogeneous gold surface. They also conclude that 
the driver of this different migration profile is the defect in Y861 phosphorylation of FAK found in cells 
seeded in the nano-patterned surface. Taking these conclusions into account, the authors also state that the 
traditional consensus surrounding the thought that cells stablish more cell-cell interactions the less cell-
ECM interactions they can set up, is not valid for the assayed specific geometry and chosen cell line. 
7. Do you believe that the experiments and the interpretation of the results are 
adequate to answer the biological/clinical questions and confirm (or not) the 
working hypothesis?  
Although the experiments are well chosen and conducted, I believe that they lack another control. The 
authors state that the controlled geometry their substrate provides is a key factor in the differential migration 
profile that the cells demonstrate in their experiments. However, they only compare the migration 
behaviour of the cells in the NPS to a homogeneously functionalized surface, failing to show how their 
system does against a non-geometrically controlled, stochastically nano-patterned surface. I believe their 
claims need to be proven too against such surfaces in order to state that the geometry is a key factor driving 
the difference, as other factors are also present in their experiments (cRGD abundance, lack of any 
PEG12K in the homogeneous photopatterned surfaces, etc). 
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8. Do you believe that the results are well interpreted and that the conclusions are 
well-founded?  
I believe that their conclusions, as I have interpreted them in question number 6, are well based, and that 
that the data presented backs these claims. The critique in the answer to question 7 refers more to disperse 
conclusions or claims found in the introduction and discussion sections, which are not found in the main 
conclusions. 
9. Is the working hypothesis confirmed to a 100% with the obtained results?  
Yes, it is confirmed if we consider my interpretation of the hypothesis of the article to be correct (no clear 
hypothesis is stated in it): HeLa cells have been shown to migrate differently in their substrate, at least if 
compared to a homogeneous one.  
10. Write a critical analysis of the article stating its strong and weak points.  
From the technical point of view, the methodology to produce the substrate and how successfully it’s able 
to harbour cell adhesion and proliferation while at the same time being photoactivatable and geometrically 
controlled is impressive. It is doubtlessly a very interesting platform for studying cell adhesion and 
interaction with the ECM, as well as cell migration, in which we can control the adhesion ligands, the size 
of the adhesion “spots”, and the distance among those in order to see how cells behave. This can be done 
too at the same time as molecular factors are also added in the system in order to further alter cell migration. 
The authors even provide the first cornerstone of the signalling pathway which might be transducing the 
information obtained from the substrate to the cytoplasm: FAK and its pY861 form.  
The weaknesses the work presents are in the lack of study on how different geometries affect migration. 
Being one of the main points of interest of the article, and reportedly, one of the benefits of the 
methodology developed by the researchers, it would be logic to expect them to show how different 
distances between the nanoparticles affect cell mobility, and also, how different geometries (i.e. a less 
organized, more stochastic organization of the nanoparticles) make the cells behave.  
11. What experiments do you believe should have been performed to improve the 
article and make the conclusions more robust?  
As previously mentioned, I would add a second control using a less precise technique for the deposition of 
the nanoparticles, based in dilution alone, in order to compare how the substrate performs in comparison 
to other substrates with uncontrolled geometries. I would implement these controls in experiment 5, 6 and 
8, also performing the in silico studies of experiment 7 on the results of the time-lapse of this novel control 
condition. 
12. Suggest a different working hypothesis based in the same biological/clinical 
question posed in this article. 
First hypothesis 
Megison et al. (2013) have described how inhibiting FAK using siRNAs or small molecule inhibitors 
reduces neuroblastoma (NB) migration. Although they did study Y397 phosphorylation, they did not 
address Y861 phosphorylation, which would have been of interest in relation to the discussed article.  
This, together with the nano-patterned photoactivatable surfaces described in the article sets a very 
interesting base for research. I would propose a hypothesis stating as follows: 
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The collectiveness of neuroblastoma cell migration is altered when adhered to the nano-patterned 
photoactivated substrate, being the individual migration pattern favoured in respect to the homogeneous 
gold surface, but it is restricted to collective migration in presence of a FAK small molecule inhibitor. 
 Second hypothesis 
As a second consideration, the platform would be also very interesting if it could be adapted into PDMS 
surfaces of stiffnesses around 0.1 to 2 kPa. It would be of great interest to study how ECM geometry would 
affect neuroblastoma differentiation. Neuroblastoma cells exhibit a certain lability, being able to 
spontaneously differentiate into cells exhibiting hallmarks of neuronal lineage (i.e. neurite outgrowth), while 
also losing their proliferative capacity. It has already been shown how surface stiffness alone can induce 
this spontaneous differentiation (Lam et al., 2010), and cell ligand geometry could also induce it or in turn, 
stall the cells in their stem cell-like stages.  
Supposing that this adaptation would be a possibility from the technical point of view, and taking into 
consideration how the nano-patterned surface highly promotes extension of cell protrusions, I would 
propose a second hypothesis: 
Neuroblastoma spontaneous differentiation is favoured when cells are seeded in nano-patterned 
photoactivated PDMS substrates of stiffnesses of 0.1 to 2 kPa.  
13. What would be the critical experiments that you would need to perform to confirm 
(or deny) the hypothesis that you have proposed in question 12? What controls 
would be needed?  
First hypothesis 
In the first place, it would be necessary to test the survivability and proliferative capacity of a neuroblastoma 
cell line in the NPS. Once this point is set out by assessing factors such as cell adhesion, Ki67 expression, 
cell growth and division, etc., the hypothesis could start to be tested.  In order to do so, I would repeat 
experiments 5 to 8 but adding two new conditions to all of them: The NPS with the small molecule inhibitor 
PF-573,228, used by Megison et al. in their article, and the homogeneous gold substrate, also with PF-
573,228. I would use as controls the versions without the molecule. I would expect similar results as in the 
discussed article, where the cells’ migration pattern effectively switches to individual when seeded in the 
NPS vs. the homogeneous gold surface but is reverted to collective in presence of PF-573,228. 
 Second hypothesis 
It is important to recall that this hypothesis is based on the premise that it is possible to manufacture a low-
stiffness PDMS substrate that is nano-patterned and photoactivatable, as well as a low-stiffness PDMS 
substrate with photoactivatable homogeneous gold surface in the same way that the substrates from the 
discussed article are possible to produce, and that neuroblastoma survivability in the NPS has been already 
tested for the first hypothesis. In order to test this second hypothesis, I would conduct the following 
experiments:  
1. Seeding of NB cells in photoactivated PDMS nano-patterned and homogeneous substrates. 
Controls: fibrinogen-coated PDMS substrates of 1 kPa and 300 kPa. Measurements: Observation 
and measurement of neurite extension using optical microscopy and image analysis software. 
2. Same experimental design and measurements as experiment number 1 but in presence of retinoic 
acid. 
Based on the results obtained from these experiments, I would decide whether to keep studying the 
molecular basis behind them. If they were promising, I would repeat the immunostainings (N-cadherin, F-
actin, and vinculin; and FAK, pY397 FAK, and pY861 FAK) performed in the discussed article, in order 
to see if FAK signalling also has a role in NB spontaneous differentiation. 
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14. Design a graphical abstract for the hypothetical article that your proposed 
hypothesis and experiments would yield. 
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Practical case 4 
Tumor cell–organized fibronectin maintenance of a 
dormant breast cancer population 
Barney, L. E., Hall, C. L., Schwartz, A. D., Parks, A. N., … Peyton, S. R. (2020). 
Science Advances, 6(11), eaaz4157. https://doi.org/10.1126/sciadv.aaz4157 
1. What is the biological and/or clinical question that the article seeks to answer? 
What is the role of the ECM in the regulation of cell dormancy, survival during the long periods of 
dormancy and regrowth and proliferation after these periods? 
2. What is the working hypothesis?  
Cancer cells are capable of secreting and assembling ECM proteins which in turn promote cell survival over 
dormancy periods but need to be degraded in order for the cells to regain their ability to proliferate when 
the dormancy-inducing conditions have passed. 
3. What does this article show? Is it of utility in the short or long term? What kind of 
work is it (Basic science, molecular biology mechanism, method, or device 
development)?  
The discussed article is a basic science work, which demonstrates the key importance of ECM composition 
and structure in cell dormancy, as well as their tight regulation by cancerous cells. Their in vitro model of 
dormancy is uniquely interesting as it allows for the study of heterogeneous dormant cell populations over 
time, in contrast to end-point in vivo studies. They also show how fibronectin is a prominent ECM protein 
regarding dormancy, and how TGFβ, ROCK, ERK and MEK signaling are tightly involved in the 
regulation of ECM deposition and assembly, ultimately affecting cell dormancy too. 
This information is of great utility, as it purveys new, very important information on one of the main 
challenges in oncology: targeting cancer cell dormancy and metastasis. 
4. What are the critical experiments and principal methods utilized to answer the 
biological/clinical questions and confirm (or not) the working hypothesis?  
1. Culturing of 23 breast cancer cell lines during 8 weeks of serum starvation in tissue culture plates, 
collagen I-laden glass coverslips, and bone marrow-recapitulating coverslips, followed by 7 days of 
recovery in serum-containing culture media. Measurements: Optical microscopy for the assessment 
of confluence and cell proliferation.  
2. Immunofluorescence staining of HCC1954 cells cultured in serum starvation during 2 and 28 days 
with antibodies for fibronectin, pan-laminin, collagen I, vitronectin, and osteopontin. Additional 
condition of 7 days recovery after 28 days starvation with fibronectin staining. Controls:  
immunofluorescence staining of fibronectin in a culture constantly exposed to serum-containing 
culture media. Measurements: fluorescence microscopy to study immunofluorescence.  
3. Immunoassay for determining MMP activity in HCC1954 cells cultured in serum-containing media, 
in serum starvation for 28 days, and in after a 7-day serum recovery after 28 days of serum 
starvation. Measurements: fluorescence microscopy. 
4. Culturing of HCC1954 cells in a decellularized fibronectin-rich matrix produced by dormant 
HCC1954 cells during 28 days of serum starvation. Controls: culturing of HCC1954 cells in 
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fibronectin coverslips and collagen I coverslips. Measurements: Fluorescence microscopy for the 
assessment of nucleuses count per imaging field (DAPI staining). 
5. Culturing of HCC1954 cells in presence of TGFβ1, TGFβ2, and LY-364749, a pan-TGFβ 
inhibitor, during 7 and 28 days of serum starvation. Controls: no TGFβ or inhibitor addition. 
Measurements: Fluorescence microscopy for the assessment of nucleuses count per imaging field 
(DAPI staining), and visualization of immunostaining of fibronectin.  
6. Culturing of HCC1954 cells in presence of anti-α5 integrin antibodies, or ROCK inhibitor Y-27632 
in various concentrations (10 µM, 1 µM, 0.1 µM) and different matrixes (collagen I and 
decellularized matrixes) according to the scheme in figure S1. Controls: grey bars in scheme (no 
inhibitor). Measurements: fluorescence microscopy for the assessment of nucleuses count per 
imaging field (DAPI staining) and visualization of fibronectin immunostaining. 
7. Culturing of HCC1954 cells in presence of anti-β1 integrin antibodies, FAK inhibitor 14, 
PD0325901 (MEK inhibitor), FR180204 (ERK inhibitor), and cilengitide in different matrixes 
(collagen I and decellularized matrixes), according to the scheme in figure S1. 
Figure S1. Scheme for the time schedule of experiments number 6 and 7. Extracted from the discussed paper. 
5. Identify the controls used in the experiments and explain their utility or function 
for the analysis of the results. 
Experiment 2 and 3 
Controls are used where cells do not undergo serum starvation, and thus are not induced to enter dormancy.  
 Experiment 4 
In order to assess how the culturing of cells in the decellularized matrix affects cell dormancy and survival, 
they use two controls where the cells are cultured in fibronectin or collagen I-lined coverslips. 
 Experiment 5, 6, and 7 
In these experiments, different molecules, antibodies, and inhibitors are presented to the cells growing or 
in dormancy-inducing conditions. All 3 of these experiments run parallel experiences where the studied 
molecule is not presented to the cells, which are used as controls.  
6. What are the conclusions?  
The authors conclude that the dynamics of fibronectin assembly and degradation regulate breast cancer cell 
dormancy in a TGFβ-dependent manner. They consider their hypothesis to be correct, while also giving 
important insights in the mechanisms underlying this fibronectin-dependent cell dormancy; they show how 
α5β1, ROCK, and TGFβ are necessary for fibronectin matrix assembly; how reactivation after dormancy 
strongly depends on MMP degradation of the fibronectin matrix; and how long-term survival depends on 
FAK-ERK signalling. They finish their conclusions stating the importance of these findings in the treatment 
of metastases: they show how targeting dormant metastasis through cell-ECM adhesion and its dependent 
signalling mechanisms could possibly be used as a therapeutic strategy, supporting the studies using 
cilengitide as an anti-metastatic drug with incredibly valuable information. 
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7. Do you believe that the experiments and the interpretation of the results are 
adequate to answer the biological/clinical questions and confirm (or not) the 
working hypothesis?  
Yes. The researchers have performed a myriad of experiments of which I have only gathered the ones I 
deem to be the most important for question number 4. These range from proteomic analysis using LC-MS 
to more common immunostainings. They screen for an incredibly wide range of cell lines and ECM 
components, and for an abundant amount of small molecule inhibitors and antibodies to test the 
mechanisms underlying cell dormancy and survival.  
8. Do you believe that the results are well interpreted and that the conclusions are 
well-founded?  
Yes, I believe their conclusions are well funded, and their data well interpreted.  
9. Is the working hypothesis confirmed to a 100% with the obtained results?  
Yes. Not only the hypothesis is perfectly confirmed – the authors provide much more information than 
fits in that hypothesis, by unravelling the mechanisms that cause it to be true. 
10. Write a critical analysis of the article stating its strong and weak points.  
The discussed article is an impressive research effort which makes use of a simple, yet very utile and efficient 
strategy: the induction of dormancy through mere serum starvation. In comparison to other articles 
discussed in former cases of study, this article makes use of a very simple technique and exploits it 
efficaciously, obtaining high amounts of valuable data which the authors have turned into interesting 
statements and claims. The experiments are in fact run in a “high-throughput” manner, testing up to 23 cell 
lines in three different conditions for a single experiment, but going further with other time and resource-
consuming experiments which can even be found in the supplementary material, such as the experiment 
studying 13 different ECM-component compositions for their coverslips in 3 cell lines, testing even 
different concentrations for some of the compositions. With proper execution and with an appealing use 
of data visualization to show and explain their results, the authors have skilfully produced a scientific 
publication of great quality.  
11. What experiments do you believe should have been performed to improve the 
article and make the conclusions more robust?  
As said, the authors have successfully answered their initially proposed questions, having their research 
ideas yielded much information as well as some new questions. One of them is specifically interesting; in 
experiment number 4, they see how cells survive dormancy on a decellularized fibronectin matrix produced 
by HCC1954 cells much more efficiently than on a coverslip functionalized with collagen I; while they have 
a lower survival rate when seeded in a coverslip functionalized with fibronectin. They then hypothesize that 
this happens due to a differential fibronectin assembly and architecture, resting at ease with this idea as it 
would be out of the scope of the article. However, they completely overlook the possibility that the 
fibronectin used in the coverslip functionalization may not be exactly the same as the one produced by the 
cancerous cells. I would thus perform an LC-MS on the decellularized ECM produced by the HCC1954 
cells and on the functionalized fibronectin matrix using the same procedures, in order to see how both 
compare.  
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12. Suggest a different working hypothesis based in the same biological/clinical 
question posed in this article. 
The idea that a molecular difference between the fibronectin used in the coverslips and the one produced 
by the HCC1954 cells could cause the difference in the survival rate between the two matrixes, rather than 
a differential architecture, caused me to perform an extensive bibliographical research on human 
fibronectin. I will summarize the hallmarks of this search which I deem necessary show the base for my 
hypothesis. 
First and foremost, it is key to point out how there exist several splice variants of fibronectin whose 
abundancy varies through development and, in the adult organism, among tissues. there are up to 20 
variants of fibronectin in humans, and regarding adults two main types exist: soluble isoforms found in 
plasma (plasma fibronectin, or pFn) and insoluble isoforms which form fibrils, deposited as part of the 
ECM (cellular fibronectin, or cFn) (Ruoslahti, 1988; White and Muro, 2011). Fibronectin presents three 
regions of alternative splicing, known as extra domain A (EDA), extra domain B (EDB), and type III 
constant segment (IIICS). Plasma Fn lacks EDA and EDB, which in contrast are present in different 
proportions in cFn.  
The fibronectin used to functionalize the coverslips, obtained from Millipore, happens to be extracted from 
human plasma and therefore is composed of pFn isoforms, thus lacking EDA and EDB domains. Tumour 
cells, in exchange, produce EDA- and EDB-containing fibronectin (cFn; Infusa et al., 1995), which strongly 
supported my suspect that the fibronectin produced by HCC1954 cells could be different from the one 
used by the researchers, giving foot to a hypothesis explaining the difference between both approaches 
which seems more plausible and concrete than a differential assembly and architecture. 
Furthermore, the authors showed in the discussed paper how exogenous TGFβ1 highly promoted cell 
dormancy and improved survival rates at 28 days of serum deprivation. White and Muro (2011) described 
how, TGFβ induces EDA-Fn expression, and as a very relevant note, also show how while total TGFβ 
production is not altered in EDA Fn-deficient mice in respect to WT mice, TGFβ activation appears to be 
significantly impaired. This implies a positive feedback loop where TGFβ induces EDA-containing 
fibronectin expression, and EDA Fn then allows for the activation of latent TGFβ, which was later 
confirmed by Ding et al. (2012). This feedback loop can in fact be seen in the results of the discussed paper 
(fig. S2). The addition of TGFβ1 not only increases cell survival at 28 days, but it also causes an increased 
deposition of fibronectin. The addition of a TGFβ receptor inhibitor severely reduces both cell survival 
and fibronectin deposition at day 28. 
All these data led me to produce the following hypothesis:  
Fibronectin-induced cancer cell dormancy requires the presence of the EDA-containing fibronectin 
splicing variant to induce TGFβ1 activation and consequent signalling, which causes a signalling cascade 
inside the cancer cell leading to increased EDA Fn secretion and increased cell survival rates during long 
periods of dormancy.  
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Figure S2. Extracted from the discussed article. Following its nomenclature and numeration: (B) Number of 
viable HCC1954 cells after 28 days of serum deprivation-induced cell dormancy in presence of TGFβ inhibitor 
LY-364947, TGFβ1, TGFβ2 and control conditions. (C) Fibronectin immunostaining (green, DAPI in blue) 
after 28 days of dormancy, in presence of LY-364947, TGFβ1, and control conditions. 
13. What would be the critical experiments that you would need to perform to confirm 
(or deny) the hypothesis that you have proposed in question 12? What controls 
would be needed?  
To test my hypothesis, I would perform the following experiments: 
1. LC-MS on the decellularized matrix produced by HCC1954 cells after 28 days of serum starvation-
induced dormancy. I would expect to find the EDA-containing splicing variant of fibronectin in 
the ECM. 
2. RT q-PCR on samples of HCC1954 cells at days 0, 7, and 28 of serum starvation, screening for the 
expression of different Fn splicing variants using exon-exclusive primers. With this I would expect 
to determine the splice variants expressed by cancer cells during dormancy 
3. In order to study localization of the different variants, I would purchase mAbs targeting the most 
interesting variants (EDA-containing, EDB-containing, pFn), and would do immunostainings of 
the cells growing in their matrixes. 
4. If EDA Fn can be purchased from a producer, I would functionalize coverslips with it and see if 
positively affects entrance into cell dormancy and survival rates as the HCC1954-produced ECM.  
14. Design a graphical abstract for the hypothetical article that your proposed 
hypothesis and experiments would yield. 
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Practical case 5 
Modulation of interactions of neuroblastoma cell lines with 
extracellular matrix proteins affects their sensitivity to 
treatment with the anti-GD2 ganglioside antibody 14G2a 
Horwacik, I., & Rokita, H. (2017). International Journal of Oncology, 50(5), 1899–1914 
https://doi.org/10.3892/ijo.2017.3959 
1. What is the biological and/or clinical question that the article seeks to answer? 
Is antiGD2 14G2a-induced neuroblastoma cytotoxicity influenced by inhibition of integrin binding to 
proteins in the extracellular matrix?  
2. What is the working hypothesis?  
The authors have published a previous work (Kowalczyk et al, 2009) showing how presence of fibronectin 
or collagen IV augmented ATP levels of cells treated with 14G2a mAb, which led them to hypothesize that 
integrin binding to ECM proteins and subsequent signaling modulates neuroblastoma cells’ sensitivity to 
14G2a-induced cytotoxicity.  
3. What does this article show? Is it of utility in the short or long term? What kind of 
work is it (Basic science, molecular biology mechanism, method, or device 
development)?  
This is a basic science article, showing how the use of inhibitors for integrins α4β1, αVβ3, and αVβ5 affects 
the efficacy of 14G2a mAb cytotoxicity in different neuroblastoma cell lines, as well as the behavior of said 
cells, including changes in their morphology, migration, and survival. The results published have a limited 
utility, as the experiments performed are focused in further investigating the cross effects that the studied 
integrins may have in the cytotoxicity induced by the 14G2a antibody, although some important 
conclusions can be taken apart from that scope.  
4. What are the critical experiments and principal methods utilized to answer the 
biological/clinical questions and confirm (or not) the working hypothesis?  
1. Culturing of IMR-32 and CHP-134 cell lines in presence of absence of 14G2a mAb (20 µg/ml, the 
same concentration is used in all further experiments) and a GD2 mimic peptide (0.23 mM), and 
in presence of both combined. Controls: culturing of cells in presence of a peptide with the 
scrambled version of the GD2 mimic (0.23 mM), in presence and absence of 14G2a mAb. 
Measurements: optical microscopy for the assessment of cellular morphology and aggregation or 
spreading; relative ATP levels. 
2. Culturing of IMR-32, CHP-134, LA-N-1, LA-N-5, and Kelly cell lines in adherent and non-
adherent culture plates, in presence or absence of 14G2a mAb. Measurements: optical microscopy 
for the assessment of cellular morphology and aggregation or spreading; relative ATP levels; 
relative caspase-3/-7 activity. 
3. Seeding of IMR-32, CHP-134, LA-N-1, LA-N-5, and Kelly cell lines on a cell adhesion array using 
antibody-coated wells screening for integrin subunits α1-α5, αV, β1-β4, and β6, and integrins αVβ3, 
αVβ5, and α5β1. Control: plates without antibody coating. Measurements: 560 nm absorbance of 
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the cells in each well stained with trypan blue, relativized against the negative control in non-coated 
wells.  
4. Culturing of IMR-32, CHP-134, and Kelly cell lines in culture plates in presence of integrin α4β1 
inhibitor BIO1211, 14G2a mAb, or both combined. Culturing of IMR-32 in fibronectin-coated 
plates under the same conditions. Controls: cells cultured with no inhibitor or mAb. Measurements: 
optical microscopy for the assessment of cellular morphology and aggregation or spreading; relative 
ATP levels. 
5. Culturing of LA-N-5, CHP-134, and Kelly cell lines in vitronectin-coated plates in presence of the 
αVβ3 and αVβ5 inhibitors cilengitide (CGT) or SB273005 (SB) alone or in combination with 
14G2a mAb. Controls: cells cultured with no inhibitor or mAb. Measurements: optical microscopy 
for the assessment of cellular morphology and aggregation or spreading; relative ATP levels; 
caspase-3/-7 activity. 
5. Identify the controls used in the experiments and explain their utility or function 
for the analysis of the results. 
Experiment 1 
A control peptide containing the scrambled sequence of the anti-14G2a peptide is used to assure the 
peptide’s specificity for the mAb. 
 Experiments 2, 4, and 5 
These experiments use common negative controls where no compound (integrin inhibitor) or mAb is used. 
 Experiment 3 
In this adhesion assay, plates with no antibody coating are used as a negative control. 
6. What are the conclusions?  
They conclude that their experiments verify that the inhibitors tested induce changes over neuroblastoma 
cell line appearance, attachment, and survival. Their conclusions are rather short and does not reflect their 
hypothesis, as they limit their claims to the point where they simply state they have broadened the 
knowledge on factors influencing 14G2a-induced cytotoxicity. They fail to conclude how the different 
inhibitors synergize with or modulate 14G2a cytotoxicity.  
7. Do you believe that the experiments and the interpretation of the results are 
adequate to answer the biological/clinical questions and confirm (or not) the 
working hypothesis?  
Although most of the experimental designs seem to be well suited to answer the questions set by the 
researchers, I believe that the measurements made in the experiments could have a deeper insight. The use 
of ATP levels can be a good manner of estimating the effect a certain molecule or mAb might have over a 
cell culture, but other quantitative measurements can be done which more robustly and reliably portray 
similar information (cell viability). Counting the number of cells per area after different periods of time or 
the use of Ki67 staining besides the measurement of ATP levels would give us a more precise insight on 
the state of the cells under the different conditions tested.  
On the other hand, the authors rely too often in the use of qualitative measurements such as cell 
morphology of estimations of confluence, when more interesting measurements could be done for both of 
these parameters to complement the information that the qualitative analysis brings, such as 
immunofluorescence addressing actin filaments or focal adhesions, or migration assays as simple as scratch-
wound healing. 
23 
 
8. Do you believe that the results are well interpreted and that the conclusions are 
well-founded?  
I believe they did not dedicate enough importance to their conclusions in the article. Where they only set 
out the vague claims commented in question 6, there are other interesting claims which can be extracted 
from their information. First, they could have mentioned how their data hint to two axis for the different 
types of cell tested; one consisting of fibronectin-α4β1-BIO1211 for IMR-32 cells; and a second one 
vitronectin-αVβ3/αVβ5-SB273005 for CHP-134, LA-N-5 and Kelly cells. They could have concluded that 
the effects of inhibitors for the most prevalent integrin type in each axis resemble those caused by 14G2a 
mAb (affectation of cell morphology, culture confluence, aggregation, etc). These claims would better adapt 
to a justification or validation of their hypothesis than their short concluding remarks, which have not even 
been redacted in a separate, dedicate section but are instead included in the discussion part. 
9. Is the working hypothesis confirmed to a 100% with the obtained results?  
I would not consider that it is. In order to prove that binding of the different integrins to ECM proteins 
modulates 14G2a-induced cytotoxicity one would need to unravel a mechanism that leads to an increase or 
decrease of said cytotoxicity in a synergistic or antagonistic manner. The results obtained by the researchers 
show how in some of the cell lines the combination of an integrin inhibitor and 14G2a have a stronger 
effect than the inhibitor or the mAb alone, but the results do not sort out that this increase or decrease in 
the measured parameter is caused simply by mere addition of two different effects (that of the inhibitor, 
plus that of the mAb). It could be possible then to argue that they act in the same way: by simply blocking 
sterically the capacity of cells to attach to the ECM. Oppositely these results could in fact be used to justify 
that the cytotoxicity caused by 14G2a is independent of protein adhesion, as the inhibition of a certain 
integrin does not “consume” the pathway exploited by 14G2a for its cytotoxicity, allowing for an increased 
cell death in presence of both.  
10. Write a critical analysis of the article stating its strong and weak points.  
The article lacks a clearly stated hypothesis, and thus, lacks the most relevant part of the conclusions in an 
article: the assessment of whether the initial hypothesis has or not been validated. Despite this vagueness 
surrounding the hypothesis, which probably stems from the inconclusiveness that the results have yielded 
surrounding the relationship between inhibition of integrin binding and 14G2a, the article does present 
relevant amounts of interesting data, especially regarding cell viability in presence of the different inhibitors. 
Albeit the authors fails to discern how the cytotoxicity of 14G2a relates to that of the integrin inhibitors, 
they have published valuable information regarding the importance of differential integrin expression for 
the interaction with fibronectin versus vitronectin in neuroblastoma cells, as well as the possibility of taking 
advantage of this blocking this interaction using specific integrin inhibitors. 
11. What experiments do you believe should have been performed to improve the 
article and make the conclusions more robust?  
Previously discussed articles, such as that by Shimizu et al. (2014; case 3), have showed the possibility of 
seeding and culturing cells in surfaces functionalized with the peptides which compose the specific integrin 
binding sites found in ECM proteins such as fibronectin. Shimizu et al. used the peptide RGD, present in 
fibronectin, which binds several integrins such as αVβ3 or αVβ5. Other peptide sequences such as 
KLDAPT, EDGIHEL or REDV could be used to functionalize culture surfaces and study how 14G2a 
affects cytotoxicity in experimental settings where a limited set of integrins (or even a single type) can 
interact with their environment, instead of seeding the cells in ECMs presenting several binding sites for 
over 10 different types of integrins and then inhibiting specific types. With this approach, the researchers 
could have had studied positive effects of specific integrin binding on 14G2a cytotoxicity (i.e. abundance 
of a single type of interaction) instead of the negative effects of integrin binding (i.e. integrin inhibition), 
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granting a new scope on the way that integrin binding and signaling interferes or synergizes with 14G2a-
induced cytotoxicity. 
12.  Suggest a different working hypothesis based in the same biological/clinical 
question posed in this article. 
Figure S3. Extracted from figure 5 of the discussed article; follows its numeration. (B) Relative ATP levels of 
IMR-32 cells seeded in fibronectin-coated wells after 2 hours. (C) Relative ATP levels of IMR-32 cells cultured 
for 3 days in fibronectin-coated wells. 
When IMR-32 cells are seeded on fibronectin-coated wells in presence of the α4β1 inhibitor BIO1211, their 
attachment to the wells is reduced compared to cells not exposed to the inhibitor (Fig. S3B). Similarly, if 
the IMR-32 cells are cultured for 72 hours in the fibronectin-coated wells, their viability is lower when in 
presence of BIO1211 (Fig S3C). This informs us of the importance of α4β1 binding to fibronectin for the 
survival and viability of the neuroblastoma cell line IMR-32.  
These experiments set a very interesting starting point for translating the experiments from case 4 using 
decellularized matrixes to study cell dormancy in breast cancer cell lines to neuroblastoma cell lines. They 
also hint at the importance of α4β1 binding in cell adhesion and viability, remarking the how the EDA 
domain in fibronectin may play an important role in this aspect. The EDA domain has a specific binding 
site for α4β1 containing an EDGIHEL motif which could be key in the regulation of cell dormancy and 
survival over long periods of time in self-produced micro-tumoral environments. A third point of interest 
can be brought from the relationship of both studies: it would be of great interest to perform the integrin 
attachment screening assay performed in the discussed article among the screenings performed in case 4 
and study whether the expression of determined integrins correlates with survival in dormant cell-produced 
fibronectin matrixes. It could be that only the cell lines expressing determinate integrins can enter dormancy 
after being seeded in the decellularized matrixes produced by HCC1954 cells.  
Combining the information of cases number 4 and number 5 I would present 3 interconnected hypotheses. 
1. The studies on serum starvation-induced cell dormancy in breast cancer cell lines conducted by 
Barney et al. (2020) can be translated to neuroblastoma. Thus, some neuroblastoma cell lines can 
also enter cell dormancy under serum starvation if seeded in a HCC1954 decellularized fibronectin 
cell matrix. Certain cell lines may in fact be capable of producing such dormancy-promoting 
matrixes. 
2. The capacity of cancer cells to survive long periods of cell dormancy when embedded in tumor 
cell-produced fibronectin matrixes depends on the expression and function of determinate integrin 
subtypes. 
3. One of the main integrins involved in the fibronectin-mediated induction of cell dormancy may be 
α4β1, effecting its role in the induction of cell dormancy through binding to the EDGIHEL motif 
present in the EDA domain of cellular fibronectin, allowing through this interaction the activation 
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of latent TGFβ1 and subsequent TGFβ1 signaling, ultimately leading to cell survival over 
dormancy periods. 
13. What would be the critical experiments that you would need to perform to confirm 
(or deny) the hypothesis that you have proposed in question 12? What controls 
would be needed?  
For the first hypothesis, it would be necessary to select a number of neuroblastoma cell lines of a certain 
diversity, and repeat some of the main experiments performed by Barney et al., starting with the screening 
for capacity of entering serum starvation-induced cell dormancy in common culture plates and in 
fibronectin and collagen I coverslips; following with the determination of whether cell lines experiment an 
improved survival over cell dormancy when grown in decellularized ECMs produced by HCC1954 cells; 
and continuing with the characterization of the importance of TGFβ signaling, ERK, MEK and ROCK 
pathways. It would be of interest to test whether the cell lines which perform best in tissue culture plates 
and functionalized coverslips also produce an ECM which improves survival during cell dormancy of cells 
cultured in their decellularized matrixes. 
For the second hypothesis, select breast cancer cell lines of the cell dormancy survival spectrum described 
by Barney et al. can be used to perform an integrin attachment screening assay such as the one performed 
in the discussed article, in order to stipulate if there’s a relationship between the expression and binding of 
certain types of integrin with the capacity to enter cell dormancy when in presence of decellularized 
fibronectin ECMs. 
Lastly, for the third hypothesis, several different approaches would be needed to validate such a complex 
hypothesis. In the first place, the presence and relative quantity of EDA-fibronectin and other splicing 
variants of fibronectin in the decellularized ECMs produced by HCC1954 cells would need to be analyzed. 
Secondly, the affinity of α4β1 for the different binding domains present in fibronectin should be addressed 
in order to confirm that the EDGIHEL domain present in EDA is relevant and key although other domains 
such as KLDAPT are present in plasma fibronectin too (which could explain the reduced adhesion of IMR-
32 cells to the pFn-functionalized wells used in fig. S3). It would then be necessary to validate that latent 
TGFβ1 activation is dependent in the presence of this domain. If these points could be validated, it would 
mean that a mechanism explaining the differential capacity of cells to enter dormancy and survive long 
periods of serum-deprivation when cultured on decellularized cellular fibronectin matrixes versus coverslips 
functionalized with plasma fibronectin has been elucidated. 
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14. Design a graphical abstract for the hypothetical article that your proposed 
hypothesis and experiments would yield. 
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